m+Medelevator.RU
← Поиск публикаций
Journal of cancer survivorship : research and practice · 2026

Identifying the informational needs and sources of support of Adolescent and Young Adult (AYA) cancer survivors to inform the development of a digital platform.

Название и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Vlooswijk C, Janssen SHM, Sleeman SHE, Pluis J, van der Graaf WTA, van de Poll-Franse LV, Husson O, van Eenbergen MC

Аннотация

PurposeThis study aimed to examine the (age-specific) informational needs and support sources used by Adolescent and Young Adult (AYA) cancer survivors throughout their cancer trajectory and socio-demographic and clinical factors associated with most common AYA-related informational needs.MethodsA cross-sectional questionnaire study was conducted among AYA cancer survivors (mean, 10.3 years after diagnosis, SD = 5.6). Informational needs and sources of support were examined via open questions and analyzed via a thematic inductive approach. Responses on informational needs were categorized according to the AYA anamnesis of the Dutch AYA "Young & Cancer" Care Network used in clinical practice. Chi-square and ANOVA tests were performed to assess differences in socio-demographic and clinical characteristics among AYA cancer survivors based on their varying levels of informational needs.ResultsIn total, 593 AYA cancer survivors were included (mean, 32.2 years at diagnosis, SD = 5.6). Most common informational needs were related to: family and children (23%), fertility and pregnancy (23%), work and reintegration (20%), peers with cancer (13%), and intimacy and sexuality (13%). Females, AYA cancer survivors diagnosed a longer time ago, those with a college/university education, those diagnosed with breast or hematological malignancies, and those treated with chemotherapy were more likely to have AYA-related informational needs. The most often used sources of support were healthcare professionals (76%), family (72%), social life (69%), and websites (47%).ConclusionsAYA cancer survivors have informational needs related to their life stage including topics like family and children, and fertility. Tailored information services and support are needed, including opportunities to connect with peers and support for relatives. By addressing the informational needs and sources of support for AYA cancer survivors, we can improve AYA care programs and empower AYA cancer survivors to better cope with the consequences associated with their disease.Implications for cancer survivorsThis study will help to inform the content of AYA websites and platforms and help AYA cancer survivors, relatives, and healthcare professionals to become more aware of the needs of AYA cancer survivors and facilitate better use of relevant information and support services.

Перевод полного текста: Перевод в очереди

Читать найденный полный текст

https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ .

Introduction

A cancer diagnosis during Adolescence and Young Adulthood is particularly challenging due to the many emotional, cognitive, and social transitions that are taking place. In this phase of life, people are becoming independent from their parents, forming their own identity, becoming more active in both intimate and emotional relationships, finishing their education, starting careers, and having children [ 1 , 2 ]. Treatment and its consequences can make Adolescents and Young Adults (AYAs) become more dependent on their parents (again); interrupt their studies, work, and/or social life; and potentially lead to loss of fertility [ 3 ].

The US Institute National Institute defined AYAs as individuals diagnosed with cancer between ages 15 and 39 years. This definition can be applied flexibly depending on the healthcare system. For instance, in the Netherlands, cancer care is divided between pediatric oncology for children (0–18 years) and medical oncology for adults (18 years and older). Consequently, the age range of 18–39 years is used as the definition of AYA cancer in this manuscript. AYA cancer survivors refer to individuals from the time of their cancer diagnosis and for the remainder of their life [ 4 ]. This phase can range from the initial diagnosis and treatment to post-treatment and long-term survivorship.

Current health services do not adequately meet the needs of many AYA cancer survivors, as highlighted by reviews on unmet needs, care experiences, and support services for AYA cancer survivors [ 5 – 8 ]. These unmet needs were related to the lack of age-appropriate facilities and healthcare professionals (HCPs) with expertise in AYA-specific issues. AYAs also identified gaps in care services, particularly concerning psychological support and social needs, including areas such as peer support. Unmet needs were found both during treatment [ 9 – 11 ] or after treatment [ 5 , 8 – 10 , 12 , 13 ]. The unmet needs of recently diagnosed AYA cancer survivors were more often related to experiences with healthcare provision, whereas the unmet needs of AYA cancer survivors who had been treated for more than 1 year ago were centered around emotional and or psychological challenges [ 5 ].

Adequate individualized information provision is a commonly reported unmet need among AYA cancer survivors [ 5 , 7 – 9 , 14 ], with two thirds of them indicating medium to high levels of unmet informational needs [ 14 ]. Associations between unmet information needs and socio-demographic and clinical factors are poorly understood. Some studies indicate that women and younger age at diagnosis have more unmet information and healthcare needs [ 12 , 13 , 15 , 16 ]. The informational needs of AYA cancer survivors seemed to partly overlap with young adult childhood cancer survivors. Recent research found that Dutch young adult childhood cancer survivors reported support needs for information related to lifestyle, fertility, and physical consequences of childhood cancer [ 17 ]. Compared to older cancer survivors, AYA cancer survivors have a greater need for information and needs differ in terms of content [ 18 , 19 ]. AYA cancer survivors searched more often for information about fertility, lifestyle, sexuality and intimacy, insurance, treatment guidelines, end of life, and alternative or complementary therapies, whereas older adult cancer survivors searched more often for information about types of cancer, cancer genetics and heredity, financial problems, and opportunities to meet peers.

HCPs, family members and friends are all well-known sources of information and/or support [ 20 ]. Moreover, religious beliefs and hobbies can also be supportive in managing and coping with cancer. Nowadays, health information is widely accessible due to the internet and new technologies [ 21 ]. AYA cancer survivors belong to a generation that has grown up in a society shaped by the Internet. Consequently, cancer survivors are increasingly using digital sources for information and social support. Studies have recommended the improvement of reputable (Internet) resources specifically for young people in the AYA cancer care worldwide [ 8 , 9 , 22 ]. In the Netherlands, AYA cancer survivors, researchers, HCPs, and other relevant stakeholders have joined forces to improve online information and services for AYA cancer survivors throughout the whole cancer continuum, as part of a research infrastructure project funded by the Dutch Cancer Society [ 23 ]. This collaboration has led to the creation of an online “young and cancer” platform [ 24 ]. Here, cancer survivors can reflect on their experiences, compare their own patient-reported outcomes with those of other patients and peers, connect with each other, and receive age-specific support. Providing AYA cancer survivors with easy access to relevant and comprehensive information contributes to a better health-related quality of life and reducing anxiety and depression [ 19 , 25 ]. To achieve this, the development of the platform involved gathering data on informational needs and sources of support used by AYA cancer survivors. Here, we present the results of this exploratory study into (1) the (age-specific) informational needs of AYA cancer survivors, (2) the socio-demographic and clinical factors associated with specific informational needs, and (3) the sources of support used by AYA cancer survivors during their cancer trajectory.

Method

Setting and study population

To improve online resources for AYA cancer survivors, an online “young and cancer” platform is being developed. We therefore conducted a preliminary research among AYA cancer survivors to investigate where they get their information from, and what information they needed during their illness. Therefore, a cross-sectional questionnaire study was conducted among AYA cancer survivors. In the Netherlands, care for cancer patients is divided into centralized pediatric oncology for children (0–18 years) and medical oncology for adults (≥ 18 years); therefore, AYA cancer survivors, aged 18 to 39 years old at cancer diagnosis were recruited [ 26 ]. They were recruited via the Dutch online platform for cancer survivors (Kanker.nl [ 27 ]), patient organizations, and the online AYA community (Fig. 1 ). They were directed to a webpage where they could sign up to receive information about the study and the informed consent procedure for participation. In addition, AYA cancer survivors who had already participated in the population-based SURVAYA study were invited to participate in this questionnaire study. The SURVAYA study focused on long-term (5–20 years) AYA cancer survivors and was conducted at the University Medical hospitals and the Netherlands Cancer Institute in the Netherlands [ 28 ]. Participants who responded to the SURVAYA study at time of this study and indicated that they could be contacted for follow-up research were invited to participate in this study. The current research was approved by the Research Ethics Review Committee of the Tilburg School of Humanities and Digital Sciences (internal code: REDC 2019.104). Cancer survivors were included who were able to read and write in Dutch and who did not have cognitive impairments that would hinder their ability to understand and complete the questionnaire, independently. Fig. 1 Flowchart of the data collection process

Fig. 1 Flowchart of the data collection process
Fig. 1 Flowchart of the data collection process

Data collection

Data collection was conducted between December 2019 and August 2020 via the PROFILES (Patient Reported Outcomes Following Initial treatment and Long-term Evaluation of Survivorship) registry [ 29 ]. PROFILES is a registry to study the impact of a cancer diagnosis and treatment in a population-based cohort of survivors. AYA cancer survivors were able to register themselves for participation in the study via the PROFILES website. After registration, they received an e-mail with a secured link to the online informed consent and questionnaire. Participants of the SURVAYA study received a study invitation by email. In case no response was received after 3 weeks, a reminder email was sent. The information about the study and the questionnaire was sent out in the Dutch language.

Measures

Socio-demographic characteristics (i.e., gender, age, marital status, children, and educational level) and clinical characteristics (year of diagnosis, tumor characteristics, and treatment modalities) were patient-reported via the questionnaire. Age-specific informational needs were assessed by the open-ended question: “What specific age-tailored information would you have wanted to receive, regarding your cancer diagnosis during adolescence and young adulthood?” Sources of support during AYA cancer survivors’ cancer trajectory were examined by the open-ended question: “What helped you the most during your illness? Consider people, websites, social media, apps, books, etc.” Respondents were asked to report anything that came to mind in open-ended text boxes, to a maximum of ten sources or topics, and to list the most important topics first. They were asked to reflect on these questions regarding their entire cancer continuum.

Statistical analyses

The open-ended responses on age-specific informational needs and sources of support were categorized independently by two researchers (C.V. and S.J.) based on the Dutch AYA anamnesis designed by the Dutch AYA “Young & Cancer” Care Network, together with AYA cancer survivors and HCPs (Supplementary file 1 ). This AYA anamnesis tool is used in the preparation and/or conduction of age-specific consultations to facilitate the identification and monitoring of AYA cancer survivors’ care needs throughout the trajectory. The AYA anamnesis contains 18 topics: fertility and pregnancy, illness and treatments, education, work and reintegration, nutrition, appearance, sport and movement, emotions, spirituality, intimacy and sexuality, friends, family and children, benefits and compensations, mortgages and insurances, late effects, complementary care, palliative care, and death. An inductive approach was used, meaning new (sub)themes were created if needed, based on the data. In line with Janssen et al., the open-ended responses on informational needs were categorized using the themes of the AYA anamnesis [ 30 ]. Multiple topics/sources could be selected for each open-ended response. A third independent researcher (O.H.) was consulted to discuss discrepancies and reach agreement. When consensus was reached, C.V. finalized the categorization.

Statistical analyses were conducted using SAS version 9.4 (SAS Institute, Cary, NC, USA, 1999). Two-sided P -values of < 0.05 were considered statistically significant. The characteristics of the study population were presented as numbers and percentages or as means with standard deviations. Chi-square and ANOVA tests were conducted to examine the differences in socio-demographic and clinical characteristics between AYA cancer survivors with no informational needs, those with an informational need regarding one theme, and those with informational needs across multiple themes.

Chi-square and independent samples t -test were used to examine the socio-demographic and clinical characteristics of the most common AYA-related informational needs identified in our study and in the literature (fertility and pregnancy, family and children, work and reintegration, peers with cancer, intimacy and sexuality, mortgages and insurances, and appearance) [ 10 , 11 , 30 , 31 ],

Results

The data collection process for this questionnaire study is shown in Fig. 1 . The majority of the participants already participated in the SURVAYA study ( n = 467), while 126 participants were recruited via the Dutch online platform (Kanker.nl [ 27 ]), patient organizations and the online AYA community. Ten participants were excluded from the analyses as they did not meet the AYA age criteria at the time of their cancer diagnosis. Consequently, a total of 593 AYA cancer survivors participated in this questionnaire study.

The majority of the participants were female (70.8%) and the mean age at time of diagnosis was 32 years (Table 1 ). Almost half of the participants were more than 10 years of post-diagnosis (48.9%) and the majority had obtained college/university education (63.6%). The most common cancer diagnoses among the participants included breast cancer (32.7%), hematological malignancies (20.2%), and gynecological cancers (11.1%). Table 1 Socio-demographic and clinical characteristics of the participants ( n = 593) AYA cancer survivors ( n = 593) No informational needs 1 informational need 2 informational needs > 2 informational needs ( n = 593) ( n = 21, 4.4%) ( n = 114, 23.7%) ( n = 115, 23.9%) ( n = 231, 48.0%) n (%) n (%) n (%) n (%) n (%) P -value Sex Female 420 (70.8%) 12 (57.1%) 73 (64.0%) 80 (69.6%) 190 (82.3%) 0 Male 173 (29.2%) 9 (42.9%) 41 (36.0%) 35 (30.4%) 41 (17.7%) Age (at diagnosis), (mean (SD)) 32.2 (5.6) 34.5 (3.8) 33.1 (5.3) 32.0 (5.7) 31.7 (5.6) 0.03862 18–24 years 76 (12.8%) 1 (4.8%) 11 (9.6%) 15 (13.0%) 33 (14.3%) 0.29781 25–32 years 184 (31.0%) 4 (19.0%) 32 (28.1%) 37 (32.2%) 78 (33.8%) 33–39 years 333 (56.2%) 16 (76.2%) 71 (62.3%) 63 (54.8%) 120 (51.9%) Years since diagnosis (mean (SD)) 10.3 (5.6) 11.1 (3.6) 12.2 (4.9) 10.8 (5.4) 8.7 (5.6) < .00012 0–5 year(s) 105 (17.7%) 1 (4.8%) 10 (8.8%) 14 (12.2%) 67 (29.0%) < .00011 > 5–10 years 198 (33.4%) 9 (42.9%) 30 (26.3%) 41 (35.7%) 80 (34.6%) > 10 years 290 (48.9%) 11 (52.4%) 74 (64.9%) 60 (52.2%) 84 (36.4%) Highest obtained educational level Primary school or equivalent 1 (0.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0.00071 Secondary school or equivalent 214 (36.2%) 11 (52.4%) 54 (47.8%) 41 (35.7%) 63 (27.3%) College/university or equivalent 376 (63.6%) 10 (47.6%) 59 (52.2%) 74 (64.3%) 168 (72.7%) Marital status (at time of questionnaire) Partner 483 (81.5%) 18 (85.7%) 96 (84.2%) 96 (83.5%) 182 (78.8%) 0.52651 Having children 371 (62.6%) 15 (71.4%) 77 (67.5%) 78 (67.8%) 137 (59.3%) 0.25631 Type of cancer1 Brain cancer 32 (5.4%) 0 (0.0%) 8 (7.0%) 10 (8.7%) 9 (3.9%) 0.17031 Breast cancer 194 (32.7%) 9 (42.9%) 34 (29.8%) 31 (27.0%) 91 (39.4%) 0.06861 Bone and soft tissue sarcoma 23 (3.9%) 1 (4.8%) 7 (6.1%) 5 (4.3%) 4 (1.7%) 0.18791 Gastrointestinal cancer 23 (3.9%) 0 (0.0%) 2 (1.8%) 3 (2.6%) 12 (5.2%) 0.26301 Gynecological cancer 66 (11.1%) 0 (0.0%) 12 (10.5%) 16 (13.9%) 27 (11.7%) 0.31861 Head and neck cancer 11 (1.9%) 1 (4.8%) 0 (0.0%) 3 (2.6%) 3 (1.3%) 0.22221 Hematological malignancies 120 (20.2%) 3 (14.3%) 20 (17.5%) 30 (26.1%) 50 (21.6%) 0.18791 Skin cancer 22 (3.7%) 1 (4.8%) 7 (6.1%) 3 (2.6%) 4 (1.7%) 0.15751 Testicular cancer 56 (9.4%) 2 (9.5%) 13 (11.4%) 13 (11.3%) 15 (6.5%) 0.34121 Thyroid cancer 27 (4.6%) 3 (14.3%) 8 (7.0%) 3 (2.6%) 8 (3.5%) 0.05111 Urological cancer 10 (1.7%) 0 (0.0%) 2 (1.8%) 3 (2.6%) 4 (1.7%) 0.85561 Other2 15 (2.5%) 1 (4.8%) 2 (1.8%) 1 (0.9%) 5 (2.2%) 0.63681 Treatment modality Surgery 420 (70.8%) 14 (66.7%) 80 (70.2%) 78 (67.8%) 167 (72.3%) 0.82381 Chemotherapy 397 (66.9%) 11 (52.4%) 71 (62.3%) 79 (68.7%) 175 (75.8%) 0.01821 Radiotherapy 341 (57.5%) 13 (61.9%) 67 (58.8%) 56 (48.7%) 136 (58.9%) 0.27591 Hormone therapy 116 (19.6%) 4 (19.0%) 26 (22.8%) 19 (16.5%) 53 (22.9%) 0.53971 Immunotherapy 57 (9.6%) 1 (4.8%) 6 (5.3%) 10 (8.7%) 36 (15.6%) 0.01671 Stem cell transplantation 35 (5.9%) 2 (9.5%) 5 (4.4%) 7 (6.1%) 14 (6.1%) 0.80311 Targeted therapy 21 (3.5%) 3 (14.3%) 4 (3.5%) 2 (1.7%) 7 (3.0%) 0.03181 Other3 13 (2.2%) 2 (9.5%) 2 (1.8%) 1 (0.9%) 5 (2.2%) 0.08541 1 Participants can have multiple types of cancer 2 Neuroendocrine tumor, lung cancer, mesothelioma, trophoblast tumor, multiple myeloma, esthesioneuroblastoma, thymus cancer and unknown 3 Radio active iodine therapy and no therapy or active surveillance

Table 1
Socio-demographic and clinical characteristics of the participants ( n = 593)
1 Participants can have multiple types of cancer 2 Neuroendocrine tumor, lung cancer, mesothelioma, trophoblast tumor, multiple myeloma, esthesioneuroblastoma, thymus cancer and unknown 3 Radio active iodine therapy and no therapy or active surveillance

AYA cancer survivors ( n = 593)
No informational needs1 informational need2 informational needs> 2 informational needs
( n = 593)( n = 21, 4.4%)( n = 114, 23.7%)( n = 115, 23.9%)( n = 231, 48.0%)
n (%)n (%)n (%)n (%)n (%)P -value
SexFemale420 (70.8%)12 (57.1%)73 (64.0%)80 (69.6%)190 (82.3%)0
Male173 (29.2%)9 (42.9%)41 (36.0%)35 (30.4%)41 (17.7%)
Age (at diagnosis), (mean (SD))32.2 (5.6)34.5 (3.8)33.1 (5.3)32.0 (5.7)31.7 (5.6)0.03862
18–24 years76 (12.8%)1 (4.8%)11 (9.6%)15 (13.0%)33 (14.3%)0.29781
25–32 years184 (31.0%)4 (19.0%)32 (28.1%)37 (32.2%)78 (33.8%)
33–39 years333 (56.2%)16 (76.2%)71 (62.3%)63 (54.8%)120 (51.9%)
Years since diagnosis (mean (SD))10.3 (5.6)11.1 (3.6)12.2 (4.9)10.8 (5.4)8.7 (5.6)< .00012
0–5 year(s)105 (17.7%)1 (4.8%)10 (8.8%)14 (12.2%)67 (29.0%)< .00011
> 5–10 years198 (33.4%)9 (42.9%)30 (26.3%)41 (35.7%)80 (34.6%)
> 10 years290 (48.9%)11 (52.4%)74 (64.9%)60 (52.2%)84 (36.4%)
Highest obtained educational levelPrimary school or equivalent1 (0.2%)0 (0.0%)0 (0.0%)0 (0.0%)0 (0.0%)0.00071
Secondary school or equivalent214 (36.2%)11 (52.4%)54 (47.8%)41 (35.7%)63 (27.3%)
College/university or equivalent376 (63.6%)10 (47.6%)59 (52.2%)74 (64.3%)168 (72.7%)
Marital status (at time of questionnaire)Partner483 (81.5%)18 (85.7%)96 (84.2%)96 (83.5%)182 (78.8%)0.52651
Having children371 (62.6%)15 (71.4%)77 (67.5%)78 (67.8%)137 (59.3%)0.25631
Type of cancer1Brain cancer32 (5.4%)0 (0.0%)8 (7.0%)10 (8.7%)9 (3.9%)0.17031
Breast cancer194 (32.7%)9 (42.9%)34 (29.8%)31 (27.0%)91 (39.4%)0.06861
Bone and soft tissue sarcoma23 (3.9%)1 (4.8%)7 (6.1%)5 (4.3%)4 (1.7%)0.18791
Gastrointestinal cancer23 (3.9%)0 (0.0%)2 (1.8%)3 (2.6%)12 (5.2%)0.26301
Gynecological cancer66 (11.1%)0 (0.0%)12 (10.5%)16 (13.9%)27 (11.7%)0.31861
Head and neck cancer11 (1.9%)1 (4.8%)0 (0.0%)3 (2.6%)3 (1.3%)0.22221
Hematological malignancies120 (20.2%)3 (14.3%)20 (17.5%)30 (26.1%)50 (21.6%)0.18791
Skin cancer22 (3.7%)1 (4.8%)7 (6.1%)3 (2.6%)4 (1.7%)0.15751
Testicular cancer56 (9.4%)2 (9.5%)13 (11.4%)13 (11.3%)15 (6.5%)0.34121
Thyroid cancer27 (4.6%)3 (14.3%)8 (7.0%)3 (2.6%)8 (3.5%)0.05111
Urological cancer10 (1.7%)0 (0.0%)2 (1.8%)3 (2.6%)4 (1.7%)0.85561
Other215 (2.5%)1 (4.8%)2 (1.8%)1 (0.9%)5 (2.2%)0.63681
Treatment modalitySurgery420 (70.8%)14 (66.7%)80 (70.2%)78 (67.8%)167 (72.3%)0.82381
Chemotherapy397 (66.9%)11 (52.4%)71 (62.3%)79 (68.7%)175 (75.8%)0.01821
Radiotherapy341 (57.5%)13 (61.9%)67 (58.8%)56 (48.7%)136 (58.9%)0.27591
Hormone therapy116 (19.6%)4 (19.0%)26 (22.8%)19 (16.5%)53 (22.9%)0.53971
Immunotherapy57 (9.6%)1 (4.8%)6 (5.3%)10 (8.7%)36 (15.6%)0.01671
Stem cell transplantation35 (5.9%)2 (9.5%)5 (4.4%)7 (6.1%)14 (6.1%)0.80311
Targeted therapy21 (3.5%)3 (14.3%)4 (3.5%)2 (1.7%)7 (3.0%)0.03181
Other313 (2.2%)2 (9.5%)2 (1.8%)1 (0.9%)5 (2.2%)0.08541

Informational needs

Data on (age-specific) informational needs were available from 481 AYA cancer survivors (Table 1 ). Among them, 21 AYA cancer survivors (4.4%) reported that they had no need for information. Nearly a quarter of the AYA cancer survivors, 23.7% reported informational needs related to a single theme, 23.9% reported informational needs on two themes, and nearly half of the AYA cancer survivors (48.0%) reported informational needs spanning more than two themes.

AYA cancer survivors with informational needs on multiple themes were more likely to be female ( p < 0.001), younger at diagnosis ( p = 0.04), more recently diagnosed with cancer ( p < 0.001), obtained college/university education ( p < 0.001), and more likely to be treated with chemotherapy ( p = 0.02), immunotherapy ( p = 0.02) and targeted therapy ( p = 0.03) (Table 1 ).

Table 2 shows a detailed overview of the (sub)themes supported by corresponding quotes from AYA cancer survivors, which offer a deeper insight into the meaning of these (sub)themes. AYA cancer survivors most commonly reported a need for information within the illness and treatment theme (65.1%). AYA cancer survivors would have liked to have had information about treatment options, the pros and cons of various treatment, risks of recurrence, heredity, and survival rates. They also wanted information on how to find the best care, such as a list of hospitals specializing their specific type of cancer and age-appropriate care. Within this theme, two subthemes emerged. AYA cancer survivors also wanted information about what they can do themselves to support their recovery and rehabilitation options (aftercare and rehabilitation), as well as about the lasting side effects of the cancer diagnosis and treatment (short- and long-term effects). “How a young body reacts to chemotherapy and recovers from it, or what the residual symptoms are.”— “Illness and treatment—short- and long-term effects” [female survivor of lymphoma] Table 2 The (Sub)themes addressing the informational needs of AYA cancer survivors throughout their cancer trajectory Themes n (%) Subtopics n (%) Quotes (EN) Illness and treatment 313 (65.1%) “Survival rates of young people” “What is the treatment procedure” “Overview of treatments with pros and cons” “Heredity” “Where can I find the best cancer care for this type of cancer” “Risk of recurrence, where to pay attention to” “How to be heard by a doctor, despite being young” “Treatment options tailored to young people” Aftercare and rehabilitation 54 (11.2%) “Recovery period” “Which type of care is available” “How can I recover as best as possible” Short- and long-term effects 185 (38.5%) “Long-term consequences” “Possible side effects of surgery and treatments” “Physical consequences of the disease and treatment” “Which complaints are associated with the consequences and which are not” “Energy after the treatment” Overarching care and life 128 (26.6%) “That life is no longer taken for granted” “Changes in your behaviour” “More positive stories, how things can go well with cancer” Information and guidance 27 (5.6%) “Website were all information is available. For example where to buy a wig. Where to buy scarves? Where to buy customized bras. Everything in one place.” “Assistance with administration” “Step-by-step plan of what you need to arrange and what to consider, such as sperm bank/insurance” “Where to get support” “Which things are handy to arrange and in what timeline (wig, for example)” “Better information on what life is like as a cancer survivor” Life after cancer 79 (16.4%) “What can you expect?” “Resuming daily life after treatment and acceptance” Fertility and pregnancy 115 (23.9%) “Risk of infertility” “Fertility in relation to treatments” “Desire to have children” “Options for (still) having children” Family and children 112 (23.3%) “How to best guide your children during the process. What can/should I tell them” “Cancer and its impact on young children within the family” “What to do when you are all alone with cancer within the family” “Disagreements within a family” “Support within the family” “How to deal with it in your relationship” “Household help (because I was young, I didn’t receive any assistance except for 3 h per week of childcare)” Emotions 111 (23.1%) “How do you deal with cancer, the uncertainty, the physical failure” “Recover from a positive self-image” “Emotional effects during curative treatment” “Anxiety after the illness (everything is suspicious)” “Mental consequences, psychological complaints” “How to deal with your ‘delay’ compared to others who continued with their lives” “Options for psychotherapy” “How to stay true to yourself in the web of advice, choiced, information, judgements, etc.” Work and reintegration 98 (20.4%) “Working and cancer” “What is the likelihood of fully returning to the workplace.” “Consequences for your job” “Returning to work when self-employed (there is a lot about returning to an employer, but not so much for self-employed individuals)” “Reintegration” Friends 95 (19.8%) “Friends” “How to deal with friends” “How to inform your friends and family” “How to involve your friends and family in such a process” “Interaction within friendships” Peers with cancer 61 (12.7%) “How to find cancer patients of your own age close by” “How important physical contact with peer is” “Peers, do they exist?” “Contact with young peers” “Peer groups” “Experiences of peers with this disease” Social life 30 (6.2%) “How do deal with being sick, feeling like you are not part of the society” “Return to society” Intimacy and sexuality 58 (12.6%) “More information on the impact on sexual possibilities after surgery” “Perhaps what effect it can have on intimacy in the relationship” Mortgages and insurances 51 (10.6%) “Influence of diagnosis on mortgage” “Options to buy a house with a non-removable cancer” “Mortgages and life insurance” “Insurance matters” “What are the consequences when applying for insurances/mortgage” “How can you get a mortgage/what alternatives are there in terms of housing” “Life insurance” “Finances (benefits, taxes (health care costs), mortgage, etc.)” “Financial consequences ((partners’) pension, life insurance, etc.)” Late effects 39 (8.1%) “Late effects” “Information regarding possible late effects in a age-appropriate manner” “Side effects at an older age” Sport and movement 37 (7.7%) “Long-term impact on your body during sports (fatigue/muscle problems/etc.)” “Reintroducing sports, my treating doctor and physiotherapist played a from pillar to post-game” “Good condition” “Recovery with exercise” Nutrition 36 (7.5%) “Nutritional advice” “Nutrition as preventive medication (vegan/dairy-free)” Benefits and compensations 35 (7.3%) “Income and cancer” “That it has financial consequences” Appearance 22 (4.6%) “How to hide physical features such as baldness” “Scar reconstruction” “Acceptance of body disfigurement” “Info on changes in appearance (hair loss, where to buy good wigs or scarves, make-up)” Complementary care 10 (2.1%) “Alternative medicine” Spirituality 5 (1.0%) “Religion and purpose” “Spirituality” “Finding meaning after cancer at a young age” “Spirituality after cancer” Education 4 (0.8%) “Studying with brain injury” “Assistance with returning to work/study” “Study and work after treatment” “How to deal with resuming to studies” Death 2 (0.4%) “Am I going to die?” “How can you prepare for your own death, and how do you involve your family in this?” Palliative care 1 (0.2%) “When are you considered as ‘exhausted all treatment options,’ and what can you still do after such a diagnosis”

Table 2
The (Sub)themes addressing the informational needs of AYA cancer survivors throughout their cancer trajectory

Themesn (%)Subtopicsn (%)Quotes (EN)
Illness and treatment313 (65.1%)“Survival rates of young people”
“What is the treatment procedure”
“Overview of treatments with pros and cons”
“Heredity”
“Where can I find the best cancer care for this type of cancer”
“Risk of recurrence, where to pay attention to”
“How to be heard by a doctor, despite being young”
“Treatment options tailored to young people”
Aftercare and rehabilitation54 (11.2%)“Recovery period”
“Which type of care is available”
“How can I recover as best as possible”
Short- and long-term effects185 (38.5%)“Long-term consequences”
“Possible side effects of surgery and treatments”
“Physical consequences of the disease and treatment”
“Which complaints are associated with the consequences and which are not”
“Energy after the treatment”
Overarching care and life128 (26.6%)“That life is no longer taken for granted”
“Changes in your behaviour”
“More positive stories, how things can go well with cancer”
Information and guidance27 (5.6%)“Website were all information is available. For example where to buy a wig. Where to buy scarves? Where to buy customized bras. Everything in one place.”
“Assistance with administration”
“Step-by-step plan of what you need to arrange and what to consider, such as sperm bank/insurance”
“Where to get support”
“Which things are handy to arrange and in what timeline (wig, for example)”
“Better information on what life is like as a cancer survivor”
Life after cancer79 (16.4%)“What can you expect?”
“Resuming daily life after treatment and acceptance”
Fertility and pregnancy115 (23.9%)“Risk of infertility”
“Fertility in relation to treatments”
“Desire to have children”
“Options for (still) having children”
Family and children112 (23.3%)“How to best guide your children during the process. What can/should I tell them”
“Cancer and its impact on young children within the family”
“What to do when you are all alone with cancer within the family”
“Disagreements within a family”
“Support within the family”
“How to deal with it in your relationship”
“Household help (because I was young, I didn’t receive any assistance except for 3 h per week of childcare)”
Emotions111 (23.1%)“How do you deal with cancer, the uncertainty, the physical failure”
“Recover from a positive self-image”
“Emotional effects during curative treatment”
“Anxiety after the illness (everything is suspicious)”
“Mental consequences, psychological complaints”
“How to deal with your ‘delay’ compared to others who continued with their lives”
“Options for psychotherapy”
“How to stay true to yourself in the web of advice, choiced, information, judgements, etc.”
Work and reintegration98 (20.4%)“Working and cancer”
“What is the likelihood of fully returning to the workplace.”
“Consequences for your job”
“Returning to work when self-employed (there is a lot about returning to an employer, but not so much for self-employed individuals)”
“Reintegration”
Friends95 (19.8%)“Friends”
“How to deal with friends”
“How to inform your friends and family”
“How to involve your friends and family in such a process”
“Interaction within friendships”
Peers with cancer61 (12.7%)“How to find cancer patients of your own age close by”
“How important physical contact with peer is”
“Peers, do they exist?”
“Contact with young peers”
“Peer groups”
“Experiences of peers with this disease”
Social life30 (6.2%)“How do deal with being sick, feeling like you are not part of the society”
“Return to society”
Intimacy and sexuality58 (12.6%)“More information on the impact on sexual possibilities after surgery”
“Perhaps what effect it can have on intimacy in the relationship”
Mortgages and insurances51 (10.6%)“Influence of diagnosis on mortgage”
“Options to buy a house with a non-removable cancer”
“Mortgages and life insurance”
“Insurance matters”
“What are the consequences when applying for insurances/mortgage”
“How can you get a mortgage/what alternatives are there in terms of housing”
“Life insurance”
“Finances (benefits, taxes (health care costs), mortgage, etc.)”
“Financial consequences ((partners’) pension, life insurance, etc.)”
Late effects39 (8.1%)“Late effects”
“Information regarding possible late effects in a age-appropriate manner”
“Side effects at an older age”
Sport and movement37 (7.7%)“Long-term impact on your body during sports (fatigue/muscle problems/etc.)”
“Reintroducing sports, my treating doctor and physiotherapist played a from pillar to post-game”
“Good condition”
“Recovery with exercise”
Nutrition36 (7.5%)“Nutritional advice”
“Nutrition as preventive medication (vegan/dairy-free)”
Benefits and compensations35 (7.3%)“Income and cancer”
“That it has financial consequences”
Appearance22 (4.6%)“How to hide physical features such as baldness”
“Scar reconstruction”
“Acceptance of body disfigurement”
“Info on changes in appearance (hair loss, where to buy good wigs or scarves, make-up)”
Complementary care10 (2.1%)“Alternative medicine”
Spirituality5 (1.0%)“Religion and purpose”
“Spirituality”
“Finding meaning after cancer at a young age”
“Spirituality after cancer”
Education4 (0.8%)“Studying with brain injury”
“Assistance with returning to work/study”
“Study and work after treatment”
“How to deal with resuming to studies”
Death2 (0.4%)“Am I going to die?”
“How can you prepare for your own death, and how do you involve your family in this?”
Palliative care1 (0.2%)“When are you considered as ‘exhausted all treatment options,’ and what can you still do after such a diagnosis”

Because many AYA cancer survivors reported informational needs that could not be categorized under one theme (i.e., not limited to a specific theme, but covering broader aspects), the overarching care and life theme (26.6%) was created. Many AYA cancer survivors expressed the need for information on how to get back on track after cancer and learn to cope with the consequences of cancer for the rest of their lives. “How to pick up the pieces after cancer, in a world where cancer seems to affect mainly older people.”— “Overarching care and life”—[female cervix carcinoma survivor]

Within the overarching care and life theme, two subthemes emerged: one focused on the need for information and guidance, and the other addressed life after cancer. “A lot of information was tailored to an older target group.”— “Overarching care and life—information and guidance” [female breast cancer survivor] ‘What changes for me?”— “Overarching care and life—life after cancer” [female breast cancer survivor]

Information on fertility and pregnancy (23.9%) focused on fertility in general or in relation to treatment, the potential risks on infertility after treatment, risks during pregnancy, and possibilities of conceiving or expanding their families. AYA cancer survivors also needed information related to family and children (23.3%). Information was needed on advice on communicating the cancer diagnosis and treatment to their children and impact on their relationship with their partner. In addition, practical support to keep the household running during treatment was also warranted. AYA cancer survivors reported that they missed (age-specific) information about psychological support during and after their diagnosis, as categorized into the emotions (23.1%) theme. They missed information about guidance in addressing their psychological complaints, including feelings of anxiety, fear of recurrence, and lack of positive self-image. “How to deal with frustrations when the things you did before are now no longer possible, and what you can do about it.”— “Emotions” [female colorectal cancer survivor]

AYA cancer survivors have indicated the need for guidance and support regarding work and reintegration (20.4%). There was a lack of information about how their employment might be affected, how to communicate with colleagues, expectations regarding a full return to work, and information for AYA cancer survivors who are self-employed. AYA cancer survivors wanted to have information on how to inform and cope with their friends (19.8%) during their disease. AYA cancer survivors had the desire to share experiences with peers with cancer. On one hand, AYA cancer survivors desire guidance on how to reintegrate into social activities (again), while on the other hand, they have trouble to maintain connections with “healthy” peers. “Offer opportunity for contact with young people with cancer. (In the rehabilitation group, I was the only young person with cancer, all others were elderly.”— “Friends—peers with cancer” [female thyroid cancer survivor]

AYA cancer survivors wanted to have information about intimacy and sexuality (12.6%). This included in particular, information on how their treatment and diagnosis affected intimacy and sexuality, tailored to the type of cancer and treatment received. Within the mortgages and insurances (10.6%) theme, AYA cancer survivors were concerned about the financial consequences of cancer. In particular, its effects on obtaining mortgages, (life) insurances, and pensions. They were worried about how cancer and its treatment might influence their ability to secure these financial necessities. Other themes that were mentioned by less than 10% of the AYA cancer survivors were late effects, sport and movement, nutrition, benefits and compensations, appearance, complementary care, spirituality, education, death, and palliative care.

Socio-demographic and clinical characteristics associated with AYA cancer survivors’ informational needs

Table 3 shows the socio-demographic and clinical characteristics associated with AYA-related informational needs. Compared to men, female AYA cancer survivors were significantly more likely to have informational needs related to fertility and pregnancy, family and children, work and reintegration, intimacy, and sexuality and appearance. Younger AYA cancer survivors were significantly more likely to have informational needs related to fertility and pregnancy, peers with cancer, mortgages and insurances, and appearance, while older AYA cancer survivors were significantly more likely to have informational needs related to family and children. AYA cancer survivors who had more recently been diagnosed with cancer were significantly more likely to have informational needs regarding family and children, work and reintegration, peers with cancer, and intimacy and sexuality. AYA cancer survivors who obtained college/university education were significantly more likely to have informational needs regarding fertility and pregnancy, peers with cancer, intimacy and sexuality, and mortgages and insurances. AYA cancer survivors who had been treated with chemotherapy were significantly more likely to have informational needs on fertility and pregnancy, family and children, work and reintegration, and intimacy and sexuality. Table 3 Socio-demographic and clinical characteristics of AYA cancer survivors with (age-specific) informational needs Fertility and pregnancy Family and children Work and reintegration Peers with cancer No informational needs Informational needs No informational needs Informational needs No informational needs Informational needs No informational needs Informational needs ( n = 366) ( n = 115) ( n = 369) ( n = 1 12) ( n = 383) ( n = 98) ( n = 420) ( n = 61) N (%) N (%) N (%) N (%) N (%) N (%) 0.01411 N (%) N (%) Sex Female 257 (70.2%) 98 (85.2%) * 261 (70.7%) 94 (83.9%) * 273 (71.3%) 82 (83.7%) 306 (72.9%) 49 (80.3%) Male 109 (29.8%) 17 (14.8%) 108 (29.3%) 18 (16.1%) 110 (28.7%) 16 (16.3%) 114 (27.1%) 12 (19.7%) Age at diagnosis (mean (SD)) 32.9 (5.5) 30.1 (5.1) * 31.9 (5.9) 33.4 (4.1) * 32.2 (5.7) 32.6 (5.1) 32.5 (5.4) 30.7 (6.3) * 18–24 years 42 (11.5%) 18 (15.7%) * 58 (15.7%) 2 (1.8%) * 51 (13.3%) 9 (9.2%) 46 (11.0%) 14 (23.0%) * 25–32 years 89 (24.3%) 62 (53.9%) 109 (29.5%) 42 (37.5%) 119 (31.1%) 32 (32.7%) 135 (32.1%) 16 (26.2%) 33–39 years 235 (64.2%) 35 (30.4%) 202 (54.7%) 68 (60.7%) 213 (55.6%) 57 (58.2%) 239 (56.9%) 31 (50.8%) Years since diagnosis (mean (SD)) 10.3 (5.44) 9.6 (5.66) 10.4 (5.29) 9.3 (6.07) 10.5 (5.5) 8.8 (5.5) * 10.5 (5.5) 7.7 (5.1) * 0–5 year(s) 63 (17.2%) 29 (25.2%) 59 (16.0%) 33 (29.5%) * 65 (17.0%) 27 (27.6%) * 74 (17.6%) 18 (29.5%) * > 5–10 years 127 (34.7%) 33 (28.7%) 131 (35.5%) 29 (25.9%) 126 (32.9%) 34 (34.7%) 131 (31.2%) 29 (47.5%) > 10 years 176 (48.1%) 53 (46.1%) 179 (48.5%) 50 (44.6%) 192 (50.1%) 37 (37.8%) 215 (51.2%) 14 (23.0%) Highest obtained educational level Primary school or equivalent 0 (0%) 0 (0%) * 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) * Secondary school or equivalent 146 (40.0%) 23 (20.0%) 137 (37.2%) 32 (28.6%) 141 (36.9%) 28 (28.6%) 155 (37.0%) 14 (23.0%) College/university or equivalent 219 (60.0%) 92 (80.0%) 231 (62.8%) 80 (71.4%) 241 (63.1%) 70 (71.4%) 264 (63.0%) 47 (77.0%) Marital status (at time of questionnaire) Partner 295 (80.6%) 97 (84.3%) 293 (79.4%) 99 (88.4%) * 314 (82.0%) 78 (79.6%) 342 (81.4%) 50 (82.0%) Having children 233 (63.7%) 74 (64.3%) 216 (58.5%) 91 (81.3%) * 250 (65.3%) 57 (58.2%) 279 (66.4%) 28 (45.9%) * Type of cancer1 Brain cancer 24 (6.6%) 3 (2.6%) 20 (5.4%) 7 (6.3%) 20 (5.2%) 7 (7.1%) 21 (5.0%) 6 (9.8%) Breast cancer 116 (31.7%) 49 (42.6%) 115 (31.2%) 50 (44.6%) * 123 (32.1%) 42 (42.9%) 147 (35.0%) 18 (29.5%) Bone and soft tissue sarcoma 16 (4.4%) 1 (0.9%) 12 (3.3%) 5 (4.5%) 16 (4.2%) 1 (1.0%) 17 (4.0%) 0 (0.0%) Gastrointestinal cancer 16 (4.4%) 1 (0.9%) 9 (2.4%) 8 (7.1%) 12 (3.1%) 5 (5.1%) 13 (3.1%) 4 (6.6%) Gynecological cancer 39 (10.7%) 16 (13.9%) 43 (11.7%) 12 (10.7%) 47 (12.3%) 8 (8.2%) 48 (11.4%) 7 (11.5%) Head and neck cancer 7 (1.9%) 0 (0.0%) 7 (1.9%) 0 (0.0%) 3 (0.8%) 4 (4.1%) * 5 (1.2%) 2 (3.3%) Hematological malignancies 69 (18.9%) 34 (29.6%) * 87 (23.6%) 16 (14.3%) * 82 (21.4%) 21 (21.4%) 85 (20.2%) 18 (29.5%) Skin cancer 14 (3.8%) 1 (0.9%) 14 (3.8%) 1 (0.9%) 14 (3.7%) 1 (1.0%) 14 (3.3%) 1 (1.6%) Testicular cancer 32 (8.7%) 11 (9.6%) 38 (10.3%) 5 (4.5%) 40 (10.4%) 3 (3.1%) * 39 (9.3%) 4 (6.6%) Thyroid cancer 20 (5.5%) 2 (1.7%) 20 (5.4%) 2 (1.8%) 18 (4.7%) 4 (4.1%) 21 (5.0%) 1 (1.6%) Urological cancer 8 (2.2%) 1 (0.9%) 7 (1.9%) 2 (1.8%) 8 (2.1%) 1 (1.0%) 9 (2.1%) 0 (0.0%) Other2 9 (2.5%) 0 (0.0%) 5 (1.4%) 4 (3.6%) 8 (2.1%) 1 (1.0%) 8 (1.9%) 1 (1.6%) Treatment modality Surgery 260 (71.0%) 79 (68.7%) 251 (68.0%) 88 (78.6%) * 267 (69.7%) 72 (73.5%) 296 (70.5%) 43 (70.5%) Chemotherapy 247 (67.5%) 89 (77.4%) * 249 (67.5%) 87 (77.7%) * 258 (67.4%) 78 (79.6%) * 291 (69.3%) 45 (73.8%) Radiotherapy 207 (56.6%) 65 (56.5%) 204 (55.3%) 68 (60.7%) 208 (54.3%) 64 (65.3%) 239 (56.9%) 33 (54.1%) Hormone therapy 74 (20.2%) 28 (24.3%) 74 (20.1%) 28 (25.0%) 81 (21.1%) 21 (21.4%) 92 (21.9%) 10 (16.4%) Immunotherapy 35 (9.6%) 18 (15.7%) 36 (9.8%) 17 (15.2%) 36 (9.4%) 17 (17.3%) * 45 (10.7%) 8 (13.1%) Stem cell transplantation 18 (4.9%) 10 (8.7%) 21 (5.7%) 7 (6.3%) 18 (4.7%) 10 (10.2%) 25 (6.0%) 3 (4.9%) Targeted therapy 12 (3.3%) 4 (3.5%) 14 (3.8%) 2 (1.8%) 14 (3.7%) 2 (2.0%) 14 (3.3%) 2 (3.3%) Other3 8 (2.2%) 2 (1.7%) 9 (2.4%) 1 (0.9%) 6 (1.6%) 4 (4.1%) 10 (2.4%) 0 (0.0%) Unmet information need Fertility and pregnancy 0 (0.0%) 115 (100.0%) * 83 (22.5%) 32 (28.6%) 91 (23.8%) 24 (24.5%) 101 (24.0%) 14 (23.0%) Family and children 80 (21.9%) 32 (27.8%) 0 (0.0%) 112 (100.0%) * 75 (19.6%) 37 (37.8%) * 102 (24.3%) 10 (16.4%) Work and reintegration 74 (20.2%) 24 (20.9%) 61 (16.5%) 37 (33.0%) * 0 (0.0%) 98 (100.0%) * 83 (19.8%) 15 (24.6%) Peers with cancer 47 (12.8%) 14 (12.2%) 51 (13.8%) 10 (8.9%) 46 (12.0%) 15 (15.3%) 0 (0.0%) 61 (100.0%) * Intimacy and sexuality 38 (10.4%) 20 (17.4%) * 35 (9.5%) 23 (20.5%) * 41 (10.7%) 17 (17.3%) 48 (11.4%) 10 (16.4%) Mortgages and insurances 31 (8.5%) 20 (17.4%) * 39 (10.6%) 12 (10.7%) 29 (7.6%) 22 (22.4%) * 44 (10.5%) 7 (11.5%) Appearance 11 (3.0%) 11 (9.6%) * 15 (4.1%) 7 (6.3%) 15 (3.9%) 7 (7.1%) 18 (4.3%) 4 (6.6%) Intimacy and sexuality Mortgages and insurances Appearance No informational needs Informational needs No informational needs Informational needs No informational needs Informational needs ( n = 423) ( n = 58) ( n = 430) ( n = 51) ( n = 459) ( n = 22) N (%) N (%) N (%) N (%) N (%) N (%) Sex Female 305 (72.1%) 50 (86.2%) * 317 (73.7%) 38 (74.5%) 334 (72.8%) 21 (95.5%) * Male 118 (27.9%) 8 (13.8%) 113 (26.3%) 13 (25.5%) 125 (27.2%) 1 (4.5%) Age at diagnosis (mean (SD)) 32.2 (5.4) 32.4 (6.5) 32.5 (5.4) 30.2 (6.4) * 32.4 (5.5) 29.5 (6.2) * 18–24 years 52 (12.3%) 8 (13.8%) 48 (11.2%) 12 (23.5%) * 55 (12.0%) 5 (22.7%) * 25–32 years 136 (32.2%) 15 (25.9%) 132 (30.7%) 19 (37.3%) 141 (30.7%) 10 (45.5%) 33–39 years 235 (55.6%) 35 (60.3%) 250 (58.1%) 20 (39.2%) 263 (57.3%) 7 (31.8%) Years since diagnosis (mean (SD)) 10.4 (5.4) * 10.2 (5.5) 10.0 (5.7) 10.2 (5.5) 8.0 (5.1) 0–5 year(s) 72 (17.0%) 20 (34.5%) * 81 (18.8%) 11 (21.6%) 85 (18.5%) 7 (31.8%) > 5–10 years 140 (33.1%) 20 (34.5%) 143 (33.3%) 17 (33.3%) 153 (33.3%) 7 (31.8%) > 10 years 211 (49.9%) 18 (31.0%) 206 (47.9%) 23 (45.1%) 221 (48.1%) 8 (36.4%) Highest obtained educational level Primary school or equivalent 0 (0%) 0 (0%) * 0 (0%) 0 (0%) * 0 (0%) 0 (0%) Secondary school or equivalent 157 (37.2%) 12 (20.7%) 160 (37.3%) 9 (17.6%) 163 (35.6%) 6 (27.3%) College/university or equivalent 265 (62.8%) 46 (79.3%) 269 (62.7%) 42 (82.4%) 295 (64.4%) 16 (72.7%) Marital status (at time of questionnaire) Partner 349 (82.5%) 43 (74.1%) 350 (81.4%) 42 (82.4%) 377 (82.1%) 15 (68.2%) Having children 275 (65.0%) 32 (55.2%) 275 (64.0%) 32 (62.7%) 296 (64.5%) 11 (50.0%) Type of cancer1 Brain cancer 25 (5.9%) 2 (3.4%) 24 (5.6%) 3 (5.9%) 26 (5.7%) 1 (4.5%) Breast cancer 139 (32.9%) 26 (44.8%) 153 (35.6%) 12 (23.5%) 152 (33.1%) 13 (59.1%) * Bone and soft tissue sarcoma 15 (3.5%) 2 (3.4%) 15 (3.5%) 2 (3.9%) 17 (3.7%) 0 (0.0%) Gastrointestinal cancer 14 (3.3%) 3 (5.2%) 15 (3.5%) 2 (3.9%) 16 (3.5%) 1 (4.5%) Gynecological cancer 42 (9.9%) 13 (22.4%) * 51 (11.9%) 4 (7.8%) 55 (12.0%) 0 (0.0%) Head and neck cancer 7 (1.7%) 0 (0.0%) 7 (1.6%) 0 (0.0%) 7 (1.5%) 0 (0.0%) Hematological malignancies 96 (22.7%) 7 (12.1%) 86 (20.0%) 17 (33.3%) * 97 (21.1%) 6 (27.3%) Skin cancer 15 (3.5%) 0 (0.0%) 13 (3.0%) 2 (3.9%) 14 (3.1%) 1 (4.5%) Testicular cancer 40 (9.5%) 3 (5.2%) 40 (9.3%) 3 (5.9%) 43 (9.4%) 0 (0.0%) Thyroid cancer 22 (5.2%) 0 (0.0%) 20 (4.7%) 2 (3.9%) 22 (4.8%) 0 (0.0%) Urological cancer 7 (1.7%) 2 (3.4%) 9 (2.1%) 0 (0.0%) 9 (2.0%) 0 (0.0%) Other2 9 (2.1%) 0 (0.0%) 7 (1.6%) 2 (3.9%) 9 (2.0%) 0 (0.0%) Treatment modality Surgery 293 (69.3%) 46 (79.3%) 307 (71.4%) 32 (62.7%) 325 (70.8%) 14 (63.6%) Chemotherapy 287 (67.8%) 49 (84.5%) * 300 (69.8%) 36 (70.6%) 317 (69.1%) 19 (86.4%) Radiotherapy 237 (56.0%) 35 (60.3%) 241 (56.0%) 31 (60.8%) 258 (56.2%) 14 (63.6%) Hormone therapy 81 (19.1%) 21 (36.2%) * 95 (22.1%) 7 (13.7%) 93 (20.3%) 9 (40.9%) * Immunotherapy 42 (9.9%) 11 (19.0%) * 46 (10.7%) 7 (13.7%) 47 (10.2%) 6 (27.3%) * Stem cell transplantation 25 (5.9%) 3 (5.2%) 22 (5.1%) 6 (11.8%) 26 (5.7%) 2 (9.1%) Targeted therapy 15 (3.5%) 1 (1.7%) 15 (3.5%) 1 (2.0%) 16 (3.5%) 0 (0.0%) Other3 10 (2.4%) 0 (0.0%) 8 (1.9%) 2 (3.9%) 10 (2.2%) 0 (0.0%) Unmet information need Fertility and pregnancy 95 (22.5%) 20 (34.5%) * 95 (22.1%) 20 (39.2%) * 104 (22.7%) 11 (50.0%) * Family and children 89 (21.0%) 23 (39.7%) * 100 (23.3%) 12 (23.5%) 105 (22.9%) 7 (31.8%) Work and reintegration 81 (19.1%) 17 (29.3%) 76 (17.7%) 22 (43.1%) * 91 (19.8%) 7 (31.8%) Peers with cancer 51 (12.1%) 10 (17.2%) 54 (12.6%) 7 (13.7%) 57 (12.4%) 4 (18.2%) Intimacy and sexuality 0 (0.0%) 58 (100.0%) * 50 (11.6%) 8 (15.7%) 54 (11.8%) 4 (18.2%) Mortgages and insurances 43 (10.2%) 8 (13.8%) 0 (0.0%) 51 (100.0%) * 48 (10.5%) 3 (13.6%) Appearance 18 (4.3%) 4 (6.9%) 19 (4.4%) 3 (5.9%) 0 (0.0%) 22 (100.0%) 1 Participants can have multiple types of cancer 2 Neuroendocrine tumor, mesothelioma, trophoblast tumor, multiple myeloma, esthesioneuroblastoma, thymus cancer, and unknown 3 Radio active iodine therapy and no therapy or active surveillance * p < 0.05

Table 3
Socio-demographic and clinical characteristics of AYA cancer survivors with (age-specific) informational needs
1 Participants can have multiple types of cancer 2 Neuroendocrine tumor, mesothelioma, trophoblast tumor, multiple myeloma, esthesioneuroblastoma, thymus cancer, and unknown 3 Radio active iodine therapy and no therapy or active surveillance * p < 0.05

Fertility and pregnancyFamily and childrenWork and reintegrationPeers with cancer
No informational needsInformational needsNo informational needsInformational needsNo informational needsInformational needsNo informational needsInformational needs
( n = 366)( n = 115)( n = 369)( n = 1 12)( n = 383)( n = 98)( n = 420)( n = 61)
N (%)N (%)N (%)N (%)N (%)N (%)0.01411N (%)N (%)
SexFemale257 (70.2%)98 (85.2%)*261 (70.7%)94 (83.9%)*273 (71.3%)82 (83.7%)306 (72.9%)49 (80.3%)
Male109 (29.8%)17 (14.8%)108 (29.3%)18 (16.1%)110 (28.7%)16 (16.3%)114 (27.1%)12 (19.7%)
Age at diagnosis (mean (SD))32.9 (5.5)30.1 (5.1)*31.9 (5.9)33.4 (4.1)*32.2 (5.7)32.6 (5.1)32.5 (5.4)30.7 (6.3)*
18–24 years42 (11.5%)18 (15.7%)*58 (15.7%)2 (1.8%)*51 (13.3%)9 (9.2%)46 (11.0%)14 (23.0%)*
25–32 years89 (24.3%)62 (53.9%)109 (29.5%)42 (37.5%)119 (31.1%)32 (32.7%)135 (32.1%)16 (26.2%)
33–39 years235 (64.2%)35 (30.4%)202 (54.7%)68 (60.7%)213 (55.6%)57 (58.2%)239 (56.9%)31 (50.8%)
Years since diagnosis (mean (SD))10.3 (5.44)9.6 (5.66)10.4 (5.29)9.3 (6.07)10.5 (5.5)8.8 (5.5)*10.5 (5.5)7.7 (5.1)*
0–5 year(s)63 (17.2%)29 (25.2%)59 (16.0%)33 (29.5%)*65 (17.0%)27 (27.6%)*74 (17.6%)18 (29.5%)*
> 5–10 years127 (34.7%)33 (28.7%)131 (35.5%)29 (25.9%)126 (32.9%)34 (34.7%)131 (31.2%)29 (47.5%)
> 10 years176 (48.1%)53 (46.1%)179 (48.5%)50 (44.6%)192 (50.1%)37 (37.8%)215 (51.2%)14 (23.0%)
Highest obtained educational levelPrimary school or equivalent0 (0%)0 (0%)*0 (0%)0 (0%)0 (0%)0 (0%)0 (0%)0 (0%)*
Secondary school or equivalent146 (40.0%)23 (20.0%)137 (37.2%)32 (28.6%)141 (36.9%)28 (28.6%)155 (37.0%)14 (23.0%)
College/university or equivalent219 (60.0%)92 (80.0%)231 (62.8%)80 (71.4%)241 (63.1%)70 (71.4%)264 (63.0%)47 (77.0%)
Marital status (at time of questionnaire)Partner295 (80.6%)97 (84.3%)293 (79.4%)99 (88.4%)*314 (82.0%)78 (79.6%)342 (81.4%)50 (82.0%)
Having children233 (63.7%)74 (64.3%)216 (58.5%)91 (81.3%)*250 (65.3%)57 (58.2%)279 (66.4%)28 (45.9%)*
Type of cancer1Brain cancer24 (6.6%)3 (2.6%)20 (5.4%)7 (6.3%)20 (5.2%)7 (7.1%)21 (5.0%)6 (9.8%)
Breast cancer116 (31.7%)49 (42.6%)115 (31.2%)50 (44.6%)*123 (32.1%)42 (42.9%)147 (35.0%)18 (29.5%)
Bone and soft tissue sarcoma16 (4.4%)1 (0.9%)12 (3.3%)5 (4.5%)16 (4.2%)1 (1.0%)17 (4.0%)0 (0.0%)
Gastrointestinal cancer16 (4.4%)1 (0.9%)9 (2.4%)8 (7.1%)12 (3.1%)5 (5.1%)13 (3.1%)4 (6.6%)
Gynecological cancer39 (10.7%)16 (13.9%)43 (11.7%)12 (10.7%)47 (12.3%)8 (8.2%)48 (11.4%)7 (11.5%)
Head and neck cancer7 (1.9%)0 (0.0%)7 (1.9%)0 (0.0%)3 (0.8%)4 (4.1%)*5 (1.2%)2 (3.3%)
Hematological malignancies69 (18.9%)34 (29.6%)*87 (23.6%)16 (14.3%)*82 (21.4%)21 (21.4%)85 (20.2%)18 (29.5%)
Skin cancer14 (3.8%)1 (0.9%)14 (3.8%)1 (0.9%)14 (3.7%)1 (1.0%)14 (3.3%)1 (1.6%)
Testicular cancer32 (8.7%)11 (9.6%)38 (10.3%)5 (4.5%)40 (10.4%)3 (3.1%)*39 (9.3%)4 (6.6%)
Thyroid cancer20 (5.5%)2 (1.7%)20 (5.4%)2 (1.8%)18 (4.7%)4 (4.1%)21 (5.0%)1 (1.6%)
Urological cancer8 (2.2%)1 (0.9%)7 (1.9%)2 (1.8%)8 (2.1%)1 (1.0%)9 (2.1%)0 (0.0%)
Other29 (2.5%)0 (0.0%)5 (1.4%)4 (3.6%)8 (2.1%)1 (1.0%)8 (1.9%)1 (1.6%)
Treatment modalitySurgery260 (71.0%)79 (68.7%)251 (68.0%)88 (78.6%)*267 (69.7%)72 (73.5%)296 (70.5%)43 (70.5%)
Chemotherapy247 (67.5%)89 (77.4%)*249 (67.5%)87 (77.7%)*258 (67.4%)78 (79.6%)*291 (69.3%)45 (73.8%)
Radiotherapy207 (56.6%)65 (56.5%)204 (55.3%)68 (60.7%)208 (54.3%)64 (65.3%)239 (56.9%)33 (54.1%)
Hormone therapy74 (20.2%)28 (24.3%)74 (20.1%)28 (25.0%)81 (21.1%)21 (21.4%)92 (21.9%)10 (16.4%)
Immunotherapy35 (9.6%)18 (15.7%)36 (9.8%)17 (15.2%)36 (9.4%)17 (17.3%)*45 (10.7%)8 (13.1%)
Stem cell transplantation18 (4.9%)10 (8.7%)21 (5.7%)7 (6.3%)18 (4.7%)10 (10.2%)25 (6.0%)3 (4.9%)
Targeted therapy12 (3.3%)4 (3.5%)14 (3.8%)2 (1.8%)14 (3.7%)2 (2.0%)14 (3.3%)2 (3.3%)
Other38 (2.2%)2 (1.7%)9 (2.4%)1 (0.9%)6 (1.6%)4 (4.1%)10 (2.4%)0 (0.0%)
Unmet information needFertility and pregnancy0 (0.0%)115 (100.0%)*83 (22.5%)32 (28.6%)91 (23.8%)24 (24.5%)101 (24.0%)14 (23.0%)
Family and children80 (21.9%)32 (27.8%)0 (0.0%)112 (100.0%)*75 (19.6%)37 (37.8%)*102 (24.3%)10 (16.4%)
Work and reintegration74 (20.2%)24 (20.9%)61 (16.5%)37 (33.0%)*0 (0.0%)98 (100.0%)*83 (19.8%)15 (24.6%)
Peers with cancer47 (12.8%)14 (12.2%)51 (13.8%)10 (8.9%)46 (12.0%)15 (15.3%)0 (0.0%)61 (100.0%)*
Intimacy and sexuality38 (10.4%)20 (17.4%)*35 (9.5%)23 (20.5%)*41 (10.7%)17 (17.3%)48 (11.4%)10 (16.4%)
Mortgages and insurances31 (8.5%)20 (17.4%)*39 (10.6%)12 (10.7%)29 (7.6%)22 (22.4%)*44 (10.5%)7 (11.5%)
Appearance11 (3.0%)11 (9.6%)*15 (4.1%)7 (6.3%)15 (3.9%)7 (7.1%)18 (4.3%)4 (6.6%)
Intimacy and sexualityMortgages and insurancesAppearance
No informational needsInformational needsNo informational needsInformational needsNo informational needsInformational needs
( n = 423)( n = 58)( n = 430)( n = 51)( n = 459)( n = 22)
N (%)N (%)N (%)N (%)N (%)N (%)
SexFemale305 (72.1%)50 (86.2%)*317 (73.7%)38 (74.5%)334 (72.8%)21 (95.5%)*
Male118 (27.9%)8 (13.8%)113 (26.3%)13 (25.5%)125 (27.2%)1 (4.5%)
Age at diagnosis (mean (SD))32.2 (5.4)32.4 (6.5)32.5 (5.4)30.2 (6.4)*32.4 (5.5)29.5 (6.2)*
18–24 years52 (12.3%)8 (13.8%)48 (11.2%)12 (23.5%)*55 (12.0%)5 (22.7%)*
25–32 years136 (32.2%)15 (25.9%)132 (30.7%)19 (37.3%)141 (30.7%)10 (45.5%)
33–39 years235 (55.6%)35 (60.3%)250 (58.1%)20 (39.2%)263 (57.3%)7 (31.8%)
Years since diagnosis (mean (SD))10.4 (5.4)*10.2 (5.5)10.0 (5.7)10.2 (5.5)8.0 (5.1)
0–5 year(s)72 (17.0%)20 (34.5%)*81 (18.8%)11 (21.6%)85 (18.5%)7 (31.8%)
> 5–10 years140 (33.1%)20 (34.5%)143 (33.3%)17 (33.3%)153 (33.3%)7 (31.8%)
> 10 years211 (49.9%)18 (31.0%)206 (47.9%)23 (45.1%)221 (48.1%)8 (36.4%)
Highest obtained educational levelPrimary school or equivalent0 (0%)0 (0%)*0 (0%)0 (0%)*0 (0%)0 (0%)
Secondary school or equivalent157 (37.2%)12 (20.7%)160 (37.3%)9 (17.6%)163 (35.6%)6 (27.3%)
College/university or equivalent265 (62.8%)46 (79.3%)269 (62.7%)42 (82.4%)295 (64.4%)16 (72.7%)
Marital status (at time of questionnaire)Partner349 (82.5%)43 (74.1%)350 (81.4%)42 (82.4%)377 (82.1%)15 (68.2%)
Having children275 (65.0%)32 (55.2%)275 (64.0%)32 (62.7%)296 (64.5%)11 (50.0%)
Type of cancer1Brain cancer25 (5.9%)2 (3.4%)24 (5.6%)3 (5.9%)26 (5.7%)1 (4.5%)
Breast cancer139 (32.9%)26 (44.8%)153 (35.6%)12 (23.5%)152 (33.1%)13 (59.1%)*
Bone and soft tissue sarcoma15 (3.5%)2 (3.4%)15 (3.5%)2 (3.9%)17 (3.7%)0 (0.0%)
Gastrointestinal cancer14 (3.3%)3 (5.2%)15 (3.5%)2 (3.9%)16 (3.5%)1 (4.5%)
Gynecological cancer42 (9.9%)13 (22.4%)*51 (11.9%)4 (7.8%)55 (12.0%)0 (0.0%)
Head and neck cancer7 (1.7%)0 (0.0%)7 (1.6%)0 (0.0%)7 (1.5%)0 (0.0%)
Hematological malignancies96 (22.7%)7 (12.1%)86 (20.0%)17 (33.3%)*97 (21.1%)6 (27.3%)
Skin cancer15 (3.5%)0 (0.0%)13 (3.0%)2 (3.9%)14 (3.1%)1 (4.5%)
Testicular cancer40 (9.5%)3 (5.2%)40 (9.3%)3 (5.9%)43 (9.4%)0 (0.0%)
Thyroid cancer22 (5.2%)0 (0.0%)20 (4.7%)2 (3.9%)22 (4.8%)0 (0.0%)
Urological cancer7 (1.7%)2 (3.4%)9 (2.1%)0 (0.0%)9 (2.0%)0 (0.0%)
Other29 (2.1%)0 (0.0%)7 (1.6%)2 (3.9%)9 (2.0%)0 (0.0%)
Treatment modalitySurgery293 (69.3%)46 (79.3%)307 (71.4%)32 (62.7%)325 (70.8%)14 (63.6%)
Chemotherapy287 (67.8%)49 (84.5%)*300 (69.8%)36 (70.6%)317 (69.1%)19 (86.4%)
Radiotherapy237 (56.0%)35 (60.3%)241 (56.0%)31 (60.8%)258 (56.2%)14 (63.6%)
Hormone therapy81 (19.1%)21 (36.2%)*95 (22.1%)7 (13.7%)93 (20.3%)9 (40.9%)*
Immunotherapy42 (9.9%)11 (19.0%)*46 (10.7%)7 (13.7%)47 (10.2%)6 (27.3%)*
Stem cell transplantation25 (5.9%)3 (5.2%)22 (5.1%)6 (11.8%)26 (5.7%)2 (9.1%)
Targeted therapy15 (3.5%)1 (1.7%)15 (3.5%)1 (2.0%)16 (3.5%)0 (0.0%)
Other310 (2.4%)0 (0.0%)8 (1.9%)2 (3.9%)10 (2.2%)0 (0.0%)
Unmet information needFertility and pregnancy95 (22.5%)20 (34.5%)*95 (22.1%)20 (39.2%)*104 (22.7%)11 (50.0%)*
Family and children89 (21.0%)23 (39.7%)*100 (23.3%)12 (23.5%)105 (22.9%)7 (31.8%)
Work and reintegration81 (19.1%)17 (29.3%)76 (17.7%)22 (43.1%)*91 (19.8%)7 (31.8%)
Peers with cancer51 (12.1%)10 (17.2%)54 (12.6%)7 (13.7%)57 (12.4%)4 (18.2%)
Intimacy and sexuality0 (0.0%)58 (100.0%)*50 (11.6%)8 (15.7%)54 (11.8%)4 (18.2%)
Mortgages and insurances43 (10.2%)8 (13.8%)0 (0.0%)51 (100.0%)*48 (10.5%)3 (13.6%)
Appearance18 (4.3%)4 (6.9%)19 (4.4%)3 (5.9%)0 (0.0%)22 (100.0%)

Sources of support

In total, 472 AYA cancer survivors listed up to ten sources of support in open-ended textboxes, which are graphically displayed in Fig. 2 . HCPs (75.5%), family (72.0%), and social life (68.5%) were most often reported as important sources of support during the illness of the AYA, followed by information (47.2%), hobbies (20.8%), work (19.6%), characteristics of a person (7.7%), and organizations (7.5%). Within the HCPs category, physicians were cited most often (58.7%), followed by nurses (29.9%), and other care givers (12.6%), such as psychotherapists, social workers, dietitians, occupational physicians, and pharmacists. In the family category, (ex-)partners were most often mentioned (32.0%), followed by parents (in law) (15.2%), and children (10.5%). Friends (46%) and peers with cancer (22.9%) were the most frequently mentioned sources of support in the social life category. Almost half of the AYA cancer survivors reported information sources such as websites (35.0%) and medical literature (18.5%). Other sources of support were hobbies (20.8%) which included sport, relaxation exercises, mediation, mindfulness, yoga; spare time and recovery (9.1%), as well as social media, gaming, and watching television (7.9%). Within the work category, colleagues and the management team (14,9%) were the most frequently mentioned sources of support. Characteristics of a person, such as positive attitude and perseverance, were also considered as helpful. Fig. 2 Sources of support utilized by AYA cancer survivors during their cancer continuum

Fig. 2 Sources of support utilized by AYA cancer survivors during their cancer continuum
Fig. 2 Sources of support utilized by AYA cancer survivors during their cancer continuum

Discussion

In addition to common informational needs related to cancer and its treatment and psychological support, AYA cancer survivors reported a need for age-specific information related to fertility, family and children, work and reintegration, peers with cancer, and intimacy and sexuality. The need for information on AYA-related topics was greater among females, AYA cancer survivors diagnosed a longer time ago, those with a college/university education, those diagnosed with breast or hematological malignancies, and AYA cancer survivors who underwent chemotherapy. HCPs, family, social life, and information, including website and medical literature, were emerged as the most often used sources of information and support throughout their disease trajectory.

Previous research found that the most common informational needs among AYA cancer survivors were related to their disease and treatment aspects and the consequences of treatment, including late effects [ 10 , 11 , 14 , 32 – 34 ]. These needs were also identified among older cancer survivors as well [ 35 ]. In our study, AYA cancer survivors reported that a lot of information is tailored to older cancer survivors and that they wanted information on age-specific aspects, such as information on treatment options specifically for young cancer survivors, risk on infertility, guidance on how to effectively support their children during their cancer trajectory, along with practical assistance in household tasks, and childcare. These findings support the need for psychological and appropriate services on these age-specific topics for AYA cancer survivors, especially after treatment is completed [ 5 , 8 , 36 , 37 ]. AYA cancer survivors reported that certain characteristics, such as having a positive mindset, perseverance, the ability to put things into perspective, and knowledge about their disease were reported as helpful during their disease. Interventions that focus on enhancing these personal characteristics may potentially enable AYA cancer survivors to better cope with their disease.

Several characteristics were associated with the need for information on AYA-related topics. In our study, younger AYA cancer survivors were significantly more likely to report informational needs on multiple themes compared to older AYA cancer survivors. This was supported by Zebrack et al. who found that unmet needs were more likely to be reported by AYA cancer survivors who were younger at diagnosis [ 37 ]. Contradictory findings were observed in another study, where younger cancer survivors (15–19 years at cancer diagnosis) had fewer unmet informational needs than those aged 30–39 years [ 34 ]. This difference may be related to their predominantly male AYA study population, who also reported less informational needs in our study. Our study reported also that younger AYA cancer survivors were more likely to have informational needs about AYA-specific themes such as fertility and pregnancy, peers with cancer, mortgages and insurances, and appearance. While older AYA cancer survivors were more likely to have informational needs related to family and children. AYA cancer survivors who completed treatment have greater informational needs than those currently undergoing treatment [ 34 ]. The main concern of AYA cancer survivors who have completed treatment was that they wanted timely and comprehensive information about the lasting impact of cancer and its treatment. In our study, short-term AYA cancer survivors had significantly more often informational needs regarding family and children, work and reintegration, peers with cancer, and intimacy and sexuality, compared to long-term cancer survivors (> 5 years). Informational needs seem to be influenced by the stage of life at which AYA cancer survivors are when diagnosed, and this should be taken into consideration when addressing informational needs by offering different things on the platform.

In our study, HCPs, mainly the physician, nurse, and the treatment team, were most frequently identified as a support source for AYA cancer survivors. This is in line with previous studies on social support among AYA cancer survivors, in which hospital staff were considered an important source of social support, largely in terms of providing informational support [ 20 ]. The study of Bennett and colleagues showed that younger survivors (aged < 60 years at diagnosis) were more likely to seek information from various sources beyond their HCPs compared to older survivors [ 38 ]. Cancer survivors with a college/university degree have greater informational needs compared to those with no education or only a primary/secondary school background. Younger cancer patients tend to have more often a college or university education compared to older cancer patients, suggesting that they may need more information to meet their informational needs. This may have implication for information services in the future. AYA cancer survivors may feel more empowered and involved in their care by actively seeking information online and discussing their options with friends and family, which is in line with societal trends towards increased patient engagement and involvement. Advances in patient- and family-centered care that have an impact on how patients actively seek information and support from HCPs are, for example, digital patient portals. They provide access to medical records, test results, and treatment plans, as well as patient-reported outcomes tools, such as those tracking symptoms. Such tools provide valuable insights into the patient’s condition for both the cancer patient and the HCP, and help them to make informed decision about their treatment.

AYA cancer survivors who are supported by close relationships with family, friends, work, or other support groups experienced less distress. McNeil et al. found that parents provide emotional, informational and instrumental social support, even for older AYA cancer survivors and those with partners and children [ 20 ]. While older adult cancer survivors are often supported by their children, AYA cancer survivors typically rely on a different support system, such as parents or peers. This responsibility can weigh heavily on partners, family members, and peers of AYA cancer survivors and can potentially lead to physical and psychological problems [ 39 , 40 ]. Relatives have their own needs, which go beyond just providing care for AYA cancer survivors. Therefore, it is important that interventions which address the needs of AYA cancer survivors include social support, but also recognize that the support system of the AYA may need support and understanding as they navigate the complexities of supporting an AYA with unique challenges.

In our study, only 8.1% of the AYA cancer survivors’ informational needs is related to late effects. The need for information on short- and long-term effects was reported more frequently (38.5%). In previous research, late effects were mentioned by almost 80% of the AYA cancer survivors [ 8 , 32 , 33 ]. An explanation for the difference in the percentage of AYA cancer survivors reporting informational needs regarding late effects could be that AYA cancer survivors may be unfamiliar with late effects and use the terms late effects and long-term effects interchangeably. The difference between them is that late effects appear months or years after the end of the treatment or diagnosis, whereas long-term effects persist for a longer period after treatment. Moreover, it could be attributed to the used definition of late effects (e.g., fertility included or not). Information on late effects is highly prioritized by childhood cancer survivors. They indicated that they would visit a website with information on late effects with personalized information, follow-up strategies, and preventive healthcare information. Further research should be conducted to gain more insight in how long-term follow-up care for AYA cancer survivors can be organized. Survivorship care plans are currently used to inform, support communication, and facilitate self-care of AYA cancer survivors regarding cancer diagnosis and follow-up [ 33 ]. Apart from providing information on medical treatment and follow-up care, these plans could be personalized, based on individual characteristics, and include details on the risk of long-term and late effects, as well as address the emotional and psychological impact. They should include a point of contact for age-specific issues, serving as navigators, referring AYA cancer survivors to appropriate HCPs. More research is needed on how these plans could be personalized based on individual characteristics using digital technologies and their impact on health outcomes.

Strength and limitations

The strength of this study is the various recruitment methods used to obtain a diverse AYA sample and thereby including a large number of AYA cancer survivors, particularly those who are long-term survivors (> 5 years of post-cancer diagnosis). Furthermore, AYA cancer survivors were diagnosed with diverse cancer types and treatment modalities. However, the study had also some limitations that should be taken into account when interpreting the results. Firstly, the findings may not be generalized to the general AYA population. As adolescents diagnosed with cancer between the ages of 15 and 17 were not included, the results cannot be generalized to this group. The study was mainly conducted among participants of the SURVAYA study. In this study, previous analyses indicated potential underrepresentation of specific subgroups, including males, AYA cancer survivors with a lower SES, those with a different cultural background, those in lower disease stages, and certain tumor types [ 28 ]. The educational backgrounds in the current study were notably higher than in the general Dutch population. Consequently, caution should be exercised when extending these findings to the wider AYA population. Secondly, our study did not use validated questionnaires to asses informational needs and sources of support [ 41 ], making it complicated to compare with international literature. It appears that the responses in this study also reflects support needs beyond information, including emotional and instrumental needs. Lastly, AYA cancer survivors were asked to fill in an open-ended response informational needs and sources from the past. Informational needs can vary over time. Preferably, a longitudinal study should be conducted that assesses informational needs across different time points.

Implications

Information and support services from the internet are becoming increasingly important for cancer survivors, especially for AYA cancer survivors. Kanker.nl [ 27 ] is the most important source for cancer-related information in the Netherlands offering a wide range of information and support sources. We found that AYA cancer survivors have general and AYA-related informational needs as well. The general information about treatments and cancer types can be addressed on the Kanker.nl website, but age-specific AYA information and services were, until recently, not yet available. In collaboration with AYAs with lived experiences, information on diverse key themes that have emerged are bundled in the “young and cancer” platform ( https://www.kanker.nl/jong ), such as fertility and pregnancy, dealing with the people around you, school and education, and work and reintegration. This “young and cancer” platform also provides separate information for relatives (e.g., parents, partners, siblings, and friends). AYA cancer survivors reported difficulties in finding peers of their own age with similar experiences. On the “young and cancer” platform, AYA with lived experience share their experiences in blogs, interviews, and podcasts, and it offers opportunities to participate in online support groups for AYA cancer survivors and their relatives. A “peer finder” tool has been developed to facilitate the search for peers based on information from their personal profile such as age, type of cancer, stage of the disease, and short- and long-term effects. AYA cancer survivors can also ask questions to HCPs on the platform, such as a social worker with specific expertise in the treatment and psychological support of AYA cancer survivors.

Future studies should address the informational needs and communication preferences of subgroups within the AYA population, including lower educated AYA cancer survivors and AYA cancer survivors with diverse cultural backgrounds [ 42 ]. Informational needs seem to vary by level of education and to be related to the ability to understand and use information about their health [ 43 ]. Previous studies have reported that 30% of the AYA cancer survivors have poor health literacy [ 44 ]. The aforementioned online platform contains, text and various formats such as images, audio, and video. Alternative methods of information provision could be used to meet the specific needs and preferences of diverse cultural background, such as sharing the experiences of these specific groups so that AYA cancer survivors can identify with them and to providing information in different languages.

Conclusion

AYA cancer survivors have a need for age-specific information, on themes relating to fertility and pregnancy, family and children, work and reintegration, peers with cancer, and intimacy and sexuality. To effectively address their informational needs, support services must tailor their resources and interventions to AYA cancer survivors and their relatives, including age-specific information and services and opportunities to connect with peers. More research is needed of subgroups such as those with lower levels of education and different cultural background, in order to tailor AYA care to a wider AYA population.

Supplementary Information

Below is the link to the electronic supplementary material. Supplementary file1 (DOCX 192 KB)

Abbreviations

Adolescents and Young Adults

Healthcare professionals

General practitioner

Dutch Cancer Society

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Acknowledgements

The authors would like to thank all the adolescent and young adult cancer survivors for their participation in this study, and the PROFILES registry group for the data collection support.

Author contributions

Conceptualization; CV, SS, WvdG, LvdP, OH, ME; Data curation; CV, SS, LvdP; Formal analysis; CV; Funding acquisition; WvdG. OH, ME; Investigation; CV; Methodology; CV, SJ, SS, OH, ME; Project administration; CV; Resources; CV; Software; CV; Supervision; WvdG, LvdP, OH, ME; Validation; CV, SJ; Visualization; CV; Writing—original draft preparation; CV; Writing—review and editing; CV, SJ, SS, JP, WvdG, LvdP, OH, ME; All authors have read and approved the final manuscript.

Funding

Dr. Olga Husson and Silvie Janssen, MSc are supported by a VIDI grant (198.007) of the Netherlands Organization for Scientific Research. Carla Vlooswijk, MSc is supported by the Dutch Cancer Society (#11788 COMPRAYA study).

KWF Kankerbestrijding,(#11788 COMPRAYA study,Netherlands Organization for Scientific Research,VIDI grant (198.007),VIDI grant (198.007)

Data availability

The data presented in this study are available on reasonable request from the corresponding author. The data are not publicly available due to privacy issues.

Declarations

Informed consent statement

Informed consent was obtained from all individual participants included in this study.

Conflict of interest

The authors declare no competing interests.

References

1. Epelman CL The adolescent and young adult with cancer: state of the art - psychosocial aspects Curr Oncol Rep 2013 15 4 325 331 10.1007/s11912-013-0324-6 23700032 Epelman CL. The adolescent and young adult with cancer: state of the art - psychosocial aspects. Curr Oncol Rep. 2013;15(4):325–31. 10.1007/s11912-013-0324-6. 23700032 10.1007/s11912-013-0324-6

2. Zebrack BJ Psychological, social, and behavioral issues for young adults with cancer Cancer 2011 117 10 Suppl 2289 2294 10.1002/cncr.26056 21523748 Zebrack BJ. Psychological, social, and behavioral issues for young adults with cancer. Cancer. 2011;117(10 Suppl):2289–94. 10.1002/cncr.26056. 21523748 10.1002/cncr.26056

3. Adolescent; young adult oncology progress review group. Closing the gap: research and care imperatives for adolescents and young adults with cancer. 2006. Available online: https://www.cancer.gov/types/aya/research/ayao-august-2006.pdf . Accessed July 2024.

4. National coalition for cancer survivorship. Our mission. http://www.canceradvocacy.org/about-us/our-mission/ . Accessed July 2024.

5. Galán S de la Vega R Miró J Needs of adolescents and young adults after cancer treatment: a systematic review Eur J Cancer Care (Engl) 2018 27 6 e12558 10.1111/ecc.12558 27507260 Galán S, de la Vega R, Miró J. Needs of adolescents and young adults after cancer treatment: a systematic review. Eur J Cancer Care (Engl). 2018;27(6):e12558. 10.1111/ecc.12558. 27507260 10.1111/ecc.12558

6. Tsangaris E Johnson J Taylor R Fern L Bryant-Lukosius D Barr R Identifying the supportive care needs of adolescent and young adult survivors of cancer: a qualitative analysis and systematic literature review Support Care Cancer 2014 22 4 947 959 10.1007/s00520-013-2053-7 24271938 Tsangaris E, Johnson J, Taylor R, Fern L, Bryant-Lukosius D, Barr R, et al. Identifying the supportive care needs of adolescent and young adult survivors of cancer: a qualitative analysis and systematic literature review. Support Care Cancer. 2014;22(4):947–59. 10.1007/s00520-013-2053-7. 24271938 10.1007/s00520-013-2053-7

7. Bibby H White V Thompson K Anazodo A What are the unmet needs and care experiences of adolescents and young adults with cancer? A systematic review J Adolesc Young Adult Oncol 2017 6 1 6 30 10.1089/jayao.2016.0012 27454408 Bibby H, White V, Thompson K, Anazodo A. What are the unmet needs and care experiences of adolescents and young adults with cancer? A systematic review. J Adolesc Young Adult Oncol. 2017;6(1):6–30. 10.1089/jayao.2016.0012. 27454408 10.1089/jayao.2016.0012

8. Lea S Martins A Fern LA Bassett M Cable M Doig G The support and information needs of adolescents and young adults with cancer when active treatment ends BMC Cancer 2020 20 1 697 10.1186/s12885-020-07197-2 32723357 PMC7388472 Lea S, Martins A, Fern LA, Bassett M, Cable M, Doig G, et al. The support and information needs of adolescents and young adults with cancer when active treatment ends. BMC Cancer. 2020;20(1):697. 10.1186/s12885-020-07197-2. 32723357 10.1186/s12885-020-07197-2 PMC7388472

9. Zebrack BJ Block R Hayes-Lattin B Embry L Aguilar C Meeske KA Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients Cancer 2013 119 1 201 214 10.1002/cncr.27713 22744865 Zebrack BJ, Block R, Hayes-Lattin B, Embry L, Aguilar C, Meeske KA, et al. Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients. Cancer. 2013;119(1):201–14. 10.1002/cncr.27713. 22744865 10.1002/cncr.27713

10. McCarthy MC McNeil R Drew S Orme L Sawyer SM Information needs of adolescent and young adult cancer patients and their parent-carers Support Care Cancer 2018 26 5 1655 1664 10.1007/s00520-017-3984-1 29222598 McCarthy MC, McNeil R, Drew S, Orme L, Sawyer SM. Information needs of adolescent and young adult cancer patients and their parent-carers. Support Care Cancer. 2018;26(5):1655–64. 10.1007/s00520-017-3984-1. 29222598 10.1007/s00520-017-3984-1

11. Greenzang KA Fasciano KM Block SD Mack JW Early information needs of adolescents and young adults about late effects of cancer treatment Cancer 2020 126 14 3281 3288 10.1002/cncr.32932 32365227 PMC7319862 Greenzang KA, Fasciano KM, Block SD, Mack JW. Early information needs of adolescents and young adults about late effects of cancer treatment. Cancer. 2020;126(14):3281–8. 10.1002/cncr.32932. 32365227 10.1002/cncr.32932 PMC7319862

12 Sender A Friedrich M Leuteritz K Nowe E Stöbel-Richter Y Mehnert A Unmet supportive care needs in young adult cancer patients: associations and changes over time. Results from the AYA-Leipzig study J Cancer Survivorship 2019 13 4 611 9 10.1007/s11764-019-00780-y 31273638 Sender A, Friedrich M, Leuteritz K, Nowe E, Stöbel-Richter Y, Mehnert A, et al. Unmet supportive care needs in young adult cancer patients: associations and changes over time. Results from the AYA-Leipzig study. J Cancer Survivorship. 2019;13(4):611–9. 10.1007/s11764-019-00780-y. 10.1007/s11764-019-00780-y 31273638

13. Bradford N Walker R Cashion C Henney R Yates P Do specialist youth cancer services meet the physical, psychological and social needs of adolescents and young adults? A cross sectional study Eur J Oncol Nurs 2020 44 101709 10.1016/j.ejon.2019.101709 31837593 Bradford N, Walker R, Cashion C, Henney R, Yates P. Do specialist youth cancer services meet the physical, psychological and social needs of adolescents and young adults? A cross sectional study. Eur J Oncol Nurs. 2020;44:101709. 10.1016/j.ejon.2019.101709. 31837593 10.1016/j.ejon.2019.101709

14. DeRouen MC Smith AW Tao L Bellizzi KM Lynch CF Parsons HM Cancer-related information needs and cancer’s impact on control over life influence health-related quality of life among adolescents and young adults with cancer Psychooncology 2015 24 9 1104 1115 10.1002/pon.3730 25611943 PMC4510026 DeRouen MC, Smith AW, Tao L, Bellizzi KM, Lynch CF, Parsons HM, et al. Cancer-related information needs and cancer’s impact on control over life influence health-related quality of life among adolescents and young adults with cancer. Psychooncology. 2015;24(9):1104–15. 10.1002/pon.3730. 25611943 10.1002/pon.3730 PMC4510026

15. Kent EE Smith AW Keegan TH Lynch CF Wu XC Hamilton AS Talking about cancer and meeting peer survivors: social information needs of adolescents and young adults diagnosed with cancer J Adolesc Young Adult Oncol 2013 2 2 44 52 10.1089/jayao.2012.0029 23781400 PMC3684139 Kent EE, Smith AW, Keegan TH, Lynch CF, Wu XC, Hamilton AS, et al. Talking about cancer and meeting peer survivors: social information needs of adolescents and young adults diagnosed with cancer. J Adolesc Young Adult Oncol. 2013;2(2):44–52. 10.1089/jayao.2012.0029. 23781400 10.1089/jayao.2012.0029 PMC3684139

16. Sawyer SM McNeil R McCarthy M Orme L Thompson K Drew S Unmet need for healthcare services in adolescents and young adults with cancer and their parent carers Support Care Cancer 2017 25 7 2229 2239 10.1007/s00520-017-3630-y 28261754 Sawyer SM, McNeil R, McCarthy M, Orme L, Thompson K, Drew S, et al. Unmet need for healthcare services in adolescents and young adults with cancer and their parent carers. Support Care Cancer. 2017;25(7):2229–39. 10.1007/s00520-017-3630-y. 28261754 10.1007/s00520-017-3630-y

17. van Erp LME Maurice-Stam H Kremer LCM Tissing WJE van der Pal HJH Beek L Support needs of Dutch young adult childhood cancer survivors Support Care Cancer 2022 30 4 3291 3302 10.1007/s00520-021-06723-7 34981198 PMC8723798 van Erp LME, Maurice-Stam H, Kremer LCM, Tissing WJE, van der Pal HJH, Beek L, et al. Support needs of Dutch young adult childhood cancer survivors. Support Care Cancer. 2022;30(4):3291–302. 10.1007/s00520-021-06723-7. 34981198 10.1007/s00520-021-06723-7 PMC8723798

18. Vlooswijk C, Husson O, Krahmer EJ, Bijlsma R, Kaal SEJ, Sleeman SHE et al. Differences in internet use and eHealth needs of adolescent and young adult versus older cancer patients; results from the PROFILES registry. Cancers (Basel). 2021;13(24). 10.3390/cancers13246308. 10.3390/cancers13246308 PMC8699784 34944928

19. Beckjord EB Arora NK McLaughlin W Oakley-Girvan I Hamilton AS Hesse BW Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care J Cancer Surviv 2008 2 3 179 189 10.1007/s11764-008-0055-0 18792791 Beckjord EB, Arora NK, McLaughlin W, Oakley-Girvan I, Hamilton AS, Hesse BW. Health-related information needs in a large and diverse sample of adult cancer survivors: implications for cancer care. J Cancer Surviv. 2008;2(3):179–89. 10.1007/s11764-008-0055-0. 18792791 10.1007/s11764-008-0055-0

20. McNeil R Egsdal M Drew S McCarthy MC Sawyer SM The changing nature of social support for adolescents and young adults with cancer Eur J Oncol Nurs 2019 43 101667 10.1016/j.ejon.2019.09.008 31586646 McNeil R, Egsdal M, Drew S, McCarthy MC, Sawyer SM. The changing nature of social support for adolescents and young adults with cancer. Eur J Oncol Nurs. 2019;43:101667. 10.1016/j.ejon.2019.09.008. 31586646 10.1016/j.ejon.2019.09.008

21. Eysenbach G The impact of the Internet on cancer outcomes CA Cancer J Clin 2003 53 6 356 371 10.3322/canjclin.53.6.356 15224975 Eysenbach G. The impact of the Internet on cancer outcomes. CA Cancer J Clin. 2003;53(6):356–71. 10.3322/canjclin.53.6.356. 15224975 10.3322/canjclin.53.6.356

22. Grace JG Schweers L Anazodo A Freyer DR Evaluating and providing quality health information for adolescents and young adults with cancer Pediatr Blood Cancer 2019 66 10 e27931 10.1002/pbc.27931 31322817 PMC7521147 Grace JG, Schweers L, Anazodo A, Freyer DR. Evaluating and providing quality health information for adolescents and young adults with cancer. Pediatr Blood Cancer. 2019;66(10):e27931. 10.1002/pbc.27931. 31322817 10.1002/pbc.27931 PMC7521147

23. Husson O, Ligtenberg MJL, van de Poll-Franse LV, Prins JB, van den Bent MJ, van Eenbergen MC et al. Comprehensive assessment of incidence, risk factors, and mechanisms of impaired medical and psychosocial health outcomes among adolescents and young adults with cancer: protocol of the prospective observational COMPRAYA cohort study. Cancers (Basel). 2021;13(10). 10.3390/cancers13102348. 10.3390/cancers13102348 PMC8152481 34068026

24. Jong en kanker. https://www.kanker.nl/jong . Accessed July 2024.

25. Husson O Mols F van de Poll-Franse LV The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review Ann Oncol 2011 22 4 761 772 10.1093/annonc/mdq413 20870912 PMC3065875 Husson O, Mols F, van de Poll-Franse LV. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol. 2011;22(4):761–72. 10.1093/annonc/mdq413. 20870912 10.1093/annonc/mdq413 PMC3065875

26. van de Graaf DL Vlooswijk C Bol N Krahmer EJ Bijlsma R Kaal S AYAs’ online information and eHealth needs: a comparison with healthcare professionals’ perceptions Cancer Med 2023 12 2 2016 2026 10.1002/cam4.5048 35879825 PMC9883566 van de Graaf DL, Vlooswijk C, Bol N, Krahmer EJ, Bijlsma R, Kaal S, et al. AYAs’ online information and eHealth needs: a comparison with healthcare professionals’ perceptions. Cancer Med. 2023;12(2):2016–26. 10.1002/cam4.5048. 35879825 10.1002/cam4.5048 PMC9883566

27. Kanker.nl. https://www.kanker.nl/jong . Accessed Oct 2023.

28. Vlooswijk C Poll-Franse LVV Janssen SHM Derksen E Reuvers MJP Bijlsma R Recruiting adolescent and young adult cancer survivors for patient-reported outcome research: experiences and sample characteristics of the SURVAYA study Curr Oncol 2022 29 8 5407 5425 10.3390/curroncol29080428 36005166 PMC9406992 Vlooswijk C, Poll-Franse LVV, Janssen SHM, Derksen E, Reuvers MJP, Bijlsma R, et al. Recruiting adolescent and young adult cancer survivors for patient-reported outcome research: experiences and sample characteristics of the SURVAYA study. Curr Oncol. 2022;29(8):5407–25. 10.3390/curroncol29080428. 36005166 10.3390/curroncol29080428 PMC9406992

29. van de Poll-Franse LV Horevoorts N van Eenbergen M Denollet J Roukema JA Aaronson NK The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts Eur J Cancer 2011 47 14 2188 2194 10.1016/j.ejca.2011.04.034 21621408 van de Poll-Franse LV, Horevoorts N, van Eenbergen M, Denollet J, Roukema JA, Aaronson NK, et al. The patient reported outcomes following initial treatment and long term evaluation of survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47(14):2188–94. 10.1016/j.ejca.2011.04.034. 21621408 10.1016/j.ejca.2011.04.034

30. Janssen SHM Vlooswijk C Manten-Horst E Sleeman SHE Bijlsma RM Kaal SEJ Learning from long-term adolescent and young adult (AYA) cancer survivors regarding their age-specific care needs to improve current AYA care programs Cancer Med 2023 12 12 13712 13731 10.1002/cam4.6001 37119039 PMC10315822 Janssen SHM, Vlooswijk C, Manten-Horst E, Sleeman SHE, Bijlsma RM, Kaal SEJ, et al. Learning from long-term adolescent and young adult (AYA) cancer survivors regarding their age-specific care needs to improve current AYA care programs. Cancer Med. 2023;12(12):13712–31. 10.1002/cam4.6001. 37119039 10.1002/cam4.6001 PMC10315822

31. Saris LMH, Vlooswijk C, Kaal SEJ, Nuver J, Bijlsma RM, van der Hulle T, et al. A negative body image among Adolescent and Young Adult (AYA) Cancer Survivors: results from the population-based SURVAYA study. Cancers (Basel). 2022;14(21). 10.3390/cancers14215243. 10.3390/cancers14215243 PMC9655157 36358662

32. Christen S Weishaupt E Vetsch J Rueegg CS Mader L Dehler S Perceived information provision and information needs in adolescent and young adult cancer survivors Eur J Cancer Care (Engl) 2019 28 1 e12892 10.1111/ecc.12892 30051513 Christen S, Weishaupt E, Vetsch J, Rueegg CS, Mader L, Dehler S, et al. Perceived information provision and information needs in adolescent and young adult cancer survivors. Eur J Cancer Care (Engl). 2019;28(1):e12892. 10.1111/ecc.12892. 30051513 10.1111/ecc.12892

33. Shay LA Parsons HM Vernon SW Survivorship care planning and unmet information and service needs among adolescent and young adult cancer survivors J Adolesc Young Adult Oncol 2017 6 2 327 332 10.1089/jayao.2016.0053 28103126 PMC5467130 Shay LA, Parsons HM, Vernon SW. Survivorship care planning and unmet information and service needs among adolescent and young adult cancer survivors. J Adolesc Young Adult Oncol. 2017;6(2):327–32. 10.1089/jayao.2016.0053. 28103126 10.1089/jayao.2016.0053 PMC5467130

34. Keegan TH Lichtensztajn DY Kato I Kent EE Wu XC West MM Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study J Cancer Surviv 2012 6 3 239 250 10.1007/s11764-012-0219-9 22457219 PMC3433596 Keegan TH, Lichtensztajn DY, Kato I, Kent EE, Wu XC, West MM, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6(3):239–50. 10.1007/s11764-012-0219-9. 22457219 10.1007/s11764-012-0219-9 PMC3433596

35. Fletcher C Flight I Chapman J Fennell K Wilson C The information needs of adult cancer survivors across the cancer continuum: a scoping review Patient Educ Couns 2017 100 3 383 410 10.1016/j.pec.2016.10.008 27765377 Fletcher C, Flight I, Chapman J, Fennell K, Wilson C. The information needs of adult cancer survivors across the cancer continuum: a scoping review. Patient Educ Couns. 2017;100(3):383–410. 10.1016/j.pec.2016.10.008. 27765377 10.1016/j.pec.2016.10.008

36. Gupta AA Edelstein K Albert-Green A D’Agostino N Assessing information and service needs of young adults with cancer at a single institution: the importance of information on cancer diagnosis, fertility preservation, diet, and exercise Support Care Cancer 2013 21 9 2477 2484 10.1007/s00520-013-1809-4 23604520 Gupta AA, Edelstein K, Albert-Green A, D’Agostino N. Assessing information and service needs of young adults with cancer at a single institution: the importance of information on cancer diagnosis, fertility preservation, diet, and exercise. Support Care Cancer. 2013;21(9):2477–84. 10.1007/s00520-013-1809-4. 23604520 10.1007/s00520-013-1809-4

37. Zebrack B Information and service needs for young adult cancer patients Support Care Cancer 2008 16 12 1353 1360 10.1007/s00520-008-0435-z 18386075 Zebrack B. Information and service needs for young adult cancer patients. Support Care Cancer. 2008;16(12):1353–60. 10.1007/s00520-008-0435-z. 18386075 10.1007/s00520-008-0435-z

38. Bennett JA Cameron LD Whitehead LC Porter D Differences between older and younger cancer survivors in seeking cancer information and using complementary/alternative medicine J Gen Intern Med 2009 24 10 1089 1094 10.1007/s11606-009-0979-8 19685099 PMC2762516 Bennett JA, Cameron LD, Whitehead LC, Porter D. Differences between older and younger cancer survivors in seeking cancer information and using complementary/alternative medicine. J Gen Intern Med. 2009;24(10):1089–94. 10.1007/s11606-009-0979-8. 19685099 10.1007/s11606-009-0979-8 PMC2762516

39. Neves MC, Bártolo A, Prins JB, Sales CMD, Monteiro S. Taking care of an adolescent and young adult cancer survivor: a systematic review of the impact of cancer on family caregivers. Int J Environ Res Public Health. 2023;20(8). 10.3390/ijerph20085488. 10.3390/ijerph20085488 PMC10138338 37107768

40. Reuvers MJP, Gedik A, Way KM, Elbersen-van de Stadt SM, van der Graaf WTA, Husson O. Caring for adolescents and young adults (AYA) with cancer: a scoping review into caregiver burdens and needs. Cancers (Basel). 2023;15(12). 10.3390/cancers15123263. 10.3390/cancers15123263 PMC10297107 37370873

41. van Eenbergen M Vromans RD Boll D Kil PJM Vos CM Krahmer EJ Changes in internet use and wishes of cancer survivors: a comparison between 2005 and 2017 Cancer 2020 126 2 408 415 10.1002/cncr.32524 31580497 PMC7004117 van Eenbergen M, Vromans RD, Boll D, Kil PJM, Vos CM, Krahmer EJ, et al. Changes in internet use and wishes of cancer survivors: a comparison between 2005 and 2017. Cancer. 2020;126(2):408–15. 10.1002/cncr.32524. 31580497 10.1002/cncr.32524 PMC7004117

42. Gedik A van Meerten E Reuvers MJP Husson O van der Graaf WTA The views of cancer patients of Turkish, Moroccan, Surinamese, and Dutch-Caribbean descent on diagnosis, treatment and prognosis: a systematic literature review J Cancer Policy 2024 39 100455 10.1016/j.jcpo.2023.100455 37984696 Gedik A, van Meerten E, Reuvers MJP, Husson O, van der Graaf WTA. The views of cancer patients of Turkish, Moroccan, Surinamese, and Dutch-Caribbean descent on diagnosis, treatment and prognosis: a systematic literature review. J Cancer Policy. 2024;39:100455. 10.1016/j.jcpo.2023.100455. 37984696 10.1016/j.jcpo.2023.100455

43. Richter D Mehnert A Forstmeyer D Ernst J Geue K Health literacy in adolescent and young adult cancer patients and its association with health outcomes J Adolesc Young Adult Oncol 2019 8 4 451 457 10.1089/jayao.2018.0118 30869557 Richter D, Mehnert A, Forstmeyer D, Ernst J, Geue K. Health literacy in adolescent and young adult cancer patients and its association with health outcomes. J Adolesc Young Adult Oncol. 2019;8(4):451–7. 10.1089/jayao.2018.0118. 30869557 10.1089/jayao.2018.0118

44. Sanders LM Federico S Klass P Abrams MA Dreyer B Literacy and child health: a systematic review Arch Pediatr Adolesc Med 2009 163 2 131 140 10.1001/archpediatrics.2008.539 19188645 Sanders LM, Federico S, Klass P, Abrams MA, Dreyer B. Literacy and child health: a systematic review. Arch Pediatr Adolesc Med. 2009;163(2):131–40. 10.1001/archpediatrics.2008.539. 19188645 10.1001/archpediatrics.2008.539

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты